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Abstract 
 
Cartilage is a vital tissue of the adult skeleton, which also serves as a transitional structure 
during early skeletal development. Sulfation of proteoglycans, especially chondroitin 
sulfate proteoglycans (CSPGs), lends unique mechanical properties to this tissue; but how 
CSPG sulfation relates to cartilage growth and development remains an open area of study. 
Though the basic biochemistry of addition and removal of sulfate groups from sulfated 
proteoglycans has been well studied, we reveal for the first time in the chicken the spatial 
distribution of sulfur throughout the cartilage template of a developing endochondral bone 
(the humerus) to show that changes in sulfation pattern are related to cartilage maturation. 
New techniques such as chemically specific X-ray fluorescence (XRF) imaging combined 
with immunohistochemistry allow the testing of the hypothesis that sulfate ester levels are 
correlated with the underlying cartilage maturation state. Our findings indicate that there 
is a significant decrease in sulfate ester levels in mature cartilage when compared with 
immature cartilage in the chicken. No significant decrease in PGs occurred at this time 
point in mature cartilage according to infrared imaging, suggesting an under-sulfated 
CSPG molecule in mature cartilage, and an unknown mechanism responsible for this shift 
in lowered sulfation levels. Decreasing sulfate esters in mature cartilage are now shown to 
be features of skeletal development for the chicken in addition to zebrafish. 
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CHAPTER 1 
1.1 Introduction  
This thesis is written in the form of manuscript-style chapters. The literature review and an 
introduction to the ideas explored further in the main study are presented in the second 
chapter, which have been published as a book chapter in the textbook Methods in Cell 
Biology: 
Brown, DS, and Eames, BF (2016). Emerging tools to study proteoglycan function during 
skeletal development. Methods in Cell Biology 134: 485-530. PMID: 27312503 
In this manuscript, the above-mentioned book chapter publication, I was granted first 
authorship and wrote it as a co-author with my supervisor Dr. Eames, whom was contacted 
by the publisher to contribute directly to a chapter. This manuscript has been altered from 
it’s original published form. Several small changes to the wording and clarification of 
concepts in this manuscript have been made at the request of the thesis defense committee. 
The thrust of my contribution was that it should serve as a literature review for the role of 
matrix proteoglycans in development, their synthesis and degradation, and emerging 
techniques in the field to visualize proteoglycans in-situ. I authored the introduction, with 
input from Dr. Eames, along with the overview of proteoglycan synthesis and degradation, 
and the section on emerging new techniques to visualize proteoglycans focused on X-ray 
fluorescence imaging Fourier transform infrared imaging. I also co-authored the final 
discussion and conclusions as they went through several revisions. I was responsible for 
creating Figures 2.1 and 2.3 (as named within the manuscript). The figures included a 
schematic for proteoglycan synthesis and degradation pathways and locations within the 
cell for Figure 2.1 and Figure 2.3 included representative images I collected myself 
demonstrating different types of information captured by these various forms of imaging. 
Writing a review paper served as a great background to my own research which is presented 
in Chapter 3. A working citation for the second, unpublished manuscript is:  
Brown, DS., Grecco, R, Hackett, MJ, George, GN, Pickering, IJ, and Eames, BF., 
"Proteoglycan sulfation decreases in mature cartilage during endochondral ossification", in 
preparation 
I am also the lead author on the second manuscript. The body of work pertains to 
experiments performed by myself throughout the course of my time in the lab of Dr. Eames. 
The rationale for this study was to determine whether sulfate ester levels decrease in mature 
cartilage in the chicken, as they were shown to in the zebrafish. After this was established, 
we wanted to try to understand if this sulfur loss can be attributed to loss of bulk PGs 
(through the lysosomal degradation pathway), or if sulfur may be decreasing in an 
independent fashion in the extracellular matrix (ECM). The latter would be a novel finding, 
pointing to an undiscovered mechanism regulating ECM sulfur levels. The main hypothesis 
of my thesis derives from previous experiments performed by Dr. Eames and Dr. Mark 
Hackett (then a post-doctoral fellow from the Department of Geological Sciences at the 
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University of Saskatchewan), which first identified the PG deficient fam20b-/- mutant 
zebrafish, and then proceeded to characterize it (Eames et al., 2011; Hackett et al., 2016). 
A trend was noticed in wild-type zebrafish sulfur levels spatially related to the different 
maturation states of cartilage (Hackett et al., 2016). 
The hypothesis in the second manuscript, which is the same overriding hypothesis guiding 
my thesis, is sulfate ester levels of proteoglycans decrease in mature cartilage. This 
manuscript is furthering our understanding from these preliminary findings in two main 
ways. Firstly, the chicken as a well-accepted model organism for skeletal development may 
differ in significant ways from zebrafish: including the timing of overall maturation, the 
much greater amount of ECM in the chick relative to zebrafish, and the different 
environments of natural selection that each organism has experienced. Secondly, our 
methodology has some different technical elements to it compared to previous studies. 
Technical differences include the analysis of adjacent sections to look at the expression of 
the maturation marker protein COLX to more accurately draw our mature cartilage regions. 
We also had the chance to look at some newly validated proteoglycan markers in the 
infrared region to determine specifically whether it was bulk proteoglycans or sulfate esters 
specifically being lost from the mature region. 
The plan for publishing the second manuscript is to include one more experimental result 
performed by another PhD student to add weight to our speculation on the cause for 
decreasing sulfur in mature cartilage. Based upon results of this thesis, we propose a 
mechanism behind what is driving these losses in sulfur in mature cartilage (i.e., a sulfatase, 
or combination of different sulfatases). With a mechanism finally proposed, this could 
directly lead to the possibility of creating an animal model which may lead to a significant 
breakthrough in understanding the role of sulfur in regulating developmental timing, as 
well as cartilage pathologies. The bulk of the work performed by myself during the course 
of my Master’s work, essentially the second manuscript (Chapter 3), sets out to correlate 
sulfur levels and the maturation state of developing cartilage. I then tried to build a case 
for biological significance of these changes with respect to normal developmental 
regulation and also diseased states of cartilage.  
 
An appendix was included at the end of the thesis. The rationale of this study was to look 
at sulfur speciation within normal and osteoarthritis (OA) affected cartilage, and to create 
maps showing the distribution of the different chemical forms of sulfur throughout both 
affected and unaffected tissue layers. This study employed the same chemically specific 
XRF imaging techniques used in Chapter 3 to look at sulfur in early development. High 
sulfation levels are an important factor in articular cartilage structural integrity. Sulfur 
exists in different chemical forms and this would be the first study looking at the spatial 
distribution of different chemical forms of sulfur in human OA tissue. This data may be 
put together later as a publication when coupled with more OA and non-OA, age-matched 
control samples imaged if more beamtime is granted for this purpose. 
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CHAPTER 2 
2. Literature Review (published manuscript): Manuscript 1 – Emerging 
Tools to Study Proteoglycan Function during Skeletal Development 
(modified from the original version) 
Brown, DS, and BF Eames (2016). Emerging tools to study proteoglycan function during 
skeletal development. Methods in Cell Biology 134: 485-530. PMID: 27312503 
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2.1 Introduction 
2.1.1 Adding function to structure: Responsive architecture and PGs 
 
The history of our understanding of proteoglycans PGs, which are special types of sugar-
coated proteins, draws strong parallels to modern architectural trends. Responsive 
architecture is an evolving field that seeks to add functionality to structures, integrating 
technological components that allow buildings to interface with their environment (El-
Khoury et al., 2012). For example, sensors in the walls determine if people are located in 
certain rooms at specific times of the day, and in response to these data, the performance 
of lighting and heating elements are optimized. So, in the history of architecture, walls in 
a building attained additional functions on top of their primary structural role. Just as 
responsive architecture adds function to structure, this review outlines similar progress in 
scientific understanding of the biological roles of PGs, interesting molecules that quite 
literally integrate the cell with the surrounding environment. 
Biochemical studies of PGs began around the turn of the 20th century with crude 
preparations from biological tissues that were rich in extracellular matrix, including 
“chondromucoid” from cartilage and anticoagulant from liver (heparin) (reviewed in Esko 
et al., 2009). In the late 1970s, new chromatographic methods permitted purification and 
identification of different PGs (Yanagishita, 1993a), and in the 1980s through the 1990’s, 
the PG synthesis pathway was dissected genetically (Banfield et al., 1995; Doege et al., 
1994; Esko, 1992; Hardingham and Fosang, 1992; Li et al., 1993; Sarkar and Esko, 1995; 
Stirpe et al., 1987; Upholt et al., 1993; Valhmu et al., 1995; Watanabe et al., 1994; Wight 
et al., 1991). These and other advancements clarified greatly how this group of molecules 
are classified and synthesized. 
PGs are a type of glycoprotein, comprised of a core protein onto which are attached one or 
many sidechains of repeating disaccharides, termed glycosaminoglycans (GAGs) 
(Hardingham and Fosang, 1992). Each specific class of PG is named based upon the exact 
sugars added in the GAG sidechain, including chondroitin sulfate (CS), heparan sulfate 
(HS), keratan sulfate (KS), and dermatan sulfate (DS) (Iozzo and Murdoch, 1996). CS 
differs from HS, for example, in that the repeating disaccharide of CS is made of glucuronic 
acid (GlcA) and N-acetylgalactosamine (GalNAc), whereas HS has GlcA and N-
acetylglucosamine (GlcNAc) repeats (Bray et al., 1944). CS and HS are similar, however, 
because they both have the same four sugar (tetrasaccharide) linker region connecting the 
GAG sidechain to the core protein via a terminal hydroxyl-linked serine residue (Iozzo and 
Murdoch, 1996). Due to this linkage, CS and HS are termed O-linked glycans, whereas N-
linked glycans, such as KS, are attached to asparagine residues (Vynios, 2014). Since most 
focus in the literature has been on biological roles of HSPG’s (Bernfield et al., 1999; Esko 
and Lindahl, 2001; Lin, 2004; Tumova et al., 2000; Turnbull et al., 2001), this review 
emphasizes more recent advances on chondroitin sulfate proteoglycan (CSPG) functions 
(Cortes et al., 2009; Hintze et al., 2012; Khatri and Schipani, 2008; Lauing et al., 2014; 
5 
Mis et al., 2014; Mizumoto et al., 2009; Prydz, 2015; Salbach et al., 2012; Sato et al., 2011; 
Tompson et al., 2009; Watanabe et al., 2010). 
Most tissues owe their structural features to the secretion of extracellular matrix by resident 
cells, a fact epitomized by skeletal cells, which secrete massive amounts of collagens and 
PGs to make cartilage and bone (Kearns et al., 1993; Sarmah et al., 2010). These secreted 
molecules and their extracellular interactions provide many of the mechanical properties 
of skeletal tissues. Collagen networks impart tensile strength, PG networks account for 
compressive resistant strength, and these networks also interact with each other directly 
(Aumailley and Gayraud, 1998; Merritt et al., 2007; Olsen, 1996). The most abundant 
cartilage PG is Aggrecan, a core protein decorated mostly with CS, but also with KS 
(Hardingham and Fosang, 1995; Kiani et al., 2002). In addition to collagen/PG interactions, 
cartilage structure also derives from interactions between Aggrecan core proteins and a 
secreted polysaccharide called hyaluronan via link proteins (Hardingham and Fosang, 
1995; Iozzo and Murdoch, 1996; Kiani et al., 2002). In summary, initial characterization 
of CSPG’s revealed these molecules to have mainly structural roles, but as in our analogy 
to responsive architecture above, subsequent studies added biological function to structure. 
Responsive architecture relies on elements that can be altered to integrate responses to the 
environment, and the analogy in the world of PGs would be sulfation of sugars. In both 
responsive architecture and in PG synthesis and homeostasis, a structure can be 
manipulated in useful ways to create an additional level of functionality beyond the original 
scope of the basic unit of support. Sulfation of PGs, or addition of sulfate esters at specific 
sugars, fits these requirements, since a structural component is modified to give additional 
functionality (Gallagher, 1989; Hardingham and Fosang, 1992; Hintze et al., 2012; Salbach 
et al., 2012). Considering these glycosylation and sulfation events, PGs exemplify the 
importance of post-translational modifications. As we detail below, sulfation modifies both 
the structural and biological features of PGs. Incorporating this theme of adding function 
to structure, this review demonstrates the relevance of PGs to normal human biology; 
couples genetic and biochemical controls of sulfated PG synthesis with the cell secretory 
and degradation pathways; and highlights emerging genetic and imaging techniques to 
elucidate further the molecular mechanisms of cartilage PG functions. 
 
2.1.2 Too much of a bad thing: PGs and disease 
 
The importance of PGs to multicellular organisms is revealed by the variety of tissues that 
are affected in human diseases associated with PG defects: heart, cartilage, bone, liver, 
kidney, ear, brain, skin, and eye (Ashworth et al., 2006; Borlot et al., 2014; Braunlin et al., 
2014; Lampe et al., 2013; Shapiro et al., 2015). Mutations underlying human disease can 
occur in core proteins or in the many classes of enzyme that regulate their post-translational 
modification. As outlined in this section, the fact that each class of enzyme in the PG 
synthesis pathway can be mutated and cause disease raises interesting questions about 
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genetic redundancy in this pathway and also whether mutant alleles are hypomorphic or 
null.  
Perhaps due to the abundant secretion of PGs by resident cells, skeletal tissues commonly 
are affected when mutations occur in the PG synthesis pathway. In fact, studies on the 
molecular genetic bases for human skeletal disease have served as a tremendous resource 
for learning about the general PG synthesis pathway. Predominant defects in skeletal 
tissues (i.e., bone or cartilage) characterize mutations to five different PG core proteins 
(Table 2). Sometimes, mutations to one core protein can underlie many diseases. For 
example, the core protein Hspg2 (previously called Perlecan) is mutated in two human 
skeletal diseases: Silverman-Handmaker type dyssegmental dysplasia and type 1 
Schwartz-Jampel syndrome (Iwata et al., 2015). As a side note about nomenclature, many 
of the proteins involved in PG synthesis were identified prior to the age of modern 
molecular genetics. Therefore, incredible degrees of discrepancy in terminology appear in 
the literature, when in many cases, authors refer to the same protein or gene. In order to 
help coordinate the field, terminology here follows accepted names according to the HUGO 
Gene Nomenclature Committee (genenames.org). 
As detailed in the next section, derivatives of many types of sugar (e.g., glucose, xylose) 
are added to PG core proteins, typically by discrete classes of enzyme. Mutations to each 
class of these glycosyltransferases cause human skeletal disease (Table 2). Modifiers of 
these sugars cause skeletal diseases when mutated. For example, mutations to Fam20c, 
which phosphorylates xylose, cause Raine syndrome, an osteosclerotic (thick bone) disease 
(Faundes et al., 2014; Kinoshita et al., 2014). Also, enzymes that regulate the sulfation of 
GAGs cause phenotypes that are predominantly manifested in the skeleton when mutated, 
including those that add and remove sulfate groups (Khatri and Schipani, 2008). In total, 
at least twenty different PG core proteins and their post-translational modifiers, when 
mutated, are known to be associated with defects that are mainly confined to human 
skeletal tissues (bone or cartilage), and about ten more have skeletal defects that might be 
secondary to disruptions in craniofacial and digit patterning (Table 2). Furthermore, 
mutations to proteins that regulate metabolism and intracellular transport of PG precursors 
(like sugars and sulfur) result in a variety of human diseases typified by skeletal defects 
(Slc35d1, Mendelian Inheritance in Man (MIM) 610804; Slc26a2, MIM 606718; Papss2, 
MIM 603005; Cant1 MIM 613165; Impad1 MIM 614010). Therefore, many human PG 
diseases only affect skeletal tissues, and as a historical fact, much of the understanding of 
PG synthesis pathway derives from these genetic studies of skeletal diseases.  
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Table 2.1. Summary of human diseases associated with mutations to genes in the proteoglycan 
synthesis pathway. 
protein MIM previous names disease (MIM) role in PG synthesis 
major 
class of 
PG 
affected 
organ(s)/tissue(
s) affected 
Aggrecan (Acan) 155760 Cspg1; Msk16; Sedk 
aggrecan type 
spondyloepimetaphyseal 
dysplasia (612813); 
Kimberley type 
spondyloepiphyseal 
dysplasia (608361); 
osteochondritis 
dissecans, short stature, 
and early-onset 
osteoarthritis (165800) core protein CSPG bone, cartilage 
Heparan sulfate 
proteoglycan of 
basement membrane 2 
(Hspg2) 142461 Perlecan (Plc); Sjs; Sja 
Silverman-Handmaker 
type dyssegmental 
dysplasia (224410); type 
1 Schwartz-Jampel 
syndrome core protein HSPG bone, cartilage 
Proteoglycan 4 (Prg4) 604283 
Superficial zone 
protein (Szp); 
Lubricin; 
Megakaryocyte-
stimulating factor 
(Msf); 
Hemangiopoietin 
(Hapo); Cacp; Jcap; 
Dol54 
camptodactyly-
arthropathy-coxa vara-
pericarditis syndrome core protein CSPG 
cartilage, 
synovium, heart 
Structural 
maintenance of 
chromosomes 3 
(Smc3) 606062 
Chondroitin sulfate 
proteoglycan 6 
(Cspg6); Bamacan 
(Bam); Human 
chromosome-
associated polypeptide 
(Hcap); Cdls3; Mmip1 
Cornelia de Lange 
syndrome 3 
core protein (but has 
conserved function in 
DNA 
replication/mitosis) CSPG 
bone, cartilage, 
brain 
Fras1-related 
extracellular matrix 
protein 1 (Frem1) 608944 
Chromosome 9 open 
reading frame 154 
(C9orf154); Bnar; 
Mota, Tilrr, Trigno2 
bifid nose with or 
without anorectal and 
renal anomalies 
(608980); Manitoba 
oculotrichoanal 
syndrome (248450); 
trigonocephaly 2 
(614485) core protein CSPG 
craniofacial, 
kidney, 
anus/rectum, 
genital tract, eye 
Fras1-related 
extracellular matrix 
protein 2 (Frem2) 608945  
Fraser syndrome 
(219000) core protein CSPG 
craniofacial, 
digits, kidney, 
lung, genital 
tract, brain 
Glypican 3 (Gpc3) 300037 
Oci5; Dgsx; Gtr2; 
Mxr7; Sdys; Sgb 
type 1 Simpson-Golabi-
Behmel syndrome 
(312870); Wilms tumor 1 core protein HSPG 
craniofacial, 
heart, eye, 
kidney, genital, 
brain 
Glypican 6 (Gpc6) 604404 Omimd1 omodysplasia 1 core protein HSPG 
bone, cartilage, 
kidney, brain 
Xylosyltransferase 1 
(Xylt1) 608124 
Xt1; UDP-D-xylose: 
proteoglycan core 
protein beta-D-
xylosyltransferase 1; 
Dbqd2 
Desbuquois dysplasia 2 
(615777) 
xylosyltransferase 
(1st sugar in 
tetrasaccharide linker 
region) CSPG? 
cartilage, bone, 
brain 
Xylosyltransferase 2 
(Xylt2) 608125 
Xt2; UDP-D-xylose: 
proteoglycan core 
protein beta-D-
xylosyltransferase 2; 
Sos 
spondyloocular 
syndrome (605822) 
xylosyltransferase 
(1st sugar in 
tetrasaccharide linker 
region) CSPG? 
bone, eye, brain, 
heart, 
craniofacial 
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Xylosylprotein beta 
1,4-
galactosyltransferase, 
polypetide 7 
(B4galt7) 604327 
Xgpt1; Xgalt1; Edsp1; 
Galactosyltransferase 
1; UDP-galactose: O-
beta-D-xylosylprotein 
4-beta-D-
galactosyltransferase 
progeroid type 1 Ehlers-
Danlos syndrome 
(130070) 
galactosyltransferase 
(2nd sugar in 
tetrasaccharide linker 
region) DSPG? 
bone, cartilage, 
muscle, skin, 
ectodermal 
appendages, 
brain 
UDP-gal: beta-gal 
beta 1,3-
galactosyltransferase, 
polypeptide 6 
(B3galt6) 615291 
Galactosyltransferase 
II (GaltII); Beta-1,3-
galactosyltransferase 
6; Beta-3-galt6; 
B3gnt1; Bgnt2; Edsp2; 
Semdjl1 
progeroid type 2 Ehlers-
Danlos syndrome 
(615349); type 1 
spondyloepimetaphyseal 
dysplasia with joint 
laxity, with or without 
fractures (271640) 
galactosyltransferase 
(3rd sugar in 
tetrasaccharide linker 
region)  
bone, cartilage, 
muscle, skin, 
heart, ligament 
Beta-1,3-
glucuronyltransferase 
3 (B3galt3) 606374 
Glucuronylstranferase 
1 (Glcat1); GlcUATI; 
Glct3; Glob; Galt3 
multiple joint 
dislocations, short 
stature, craniofacial 
dysmorphism, and 
congenital heart defects 
(245600) 
glucuronyltransferase 
(4th sugar in 
tetrasaccharide linker 
region)  
bone, cartilage, 
heart, teeth, skin 
Exostosin 
glycosyltransferase 1 
(Ext1) 608177 
Lgcr; Lgs; Trps2; Ttv; 
Dext1 
chondrosarcoma 
(215300); type 1 multiple 
exostoses (133700) 
glycosyltransferase 
(repeating HS 
disaccharide) HSPG cartilage, bone 
Exostosin 
glycosyltransferase 2 
(Ext2) 608210 Sotv 
type 2 multiple exostoses 
(133701) 
glycosyltransferase 
(repeating HS 
disaccharide) HSPG cartilage, bone 
Exostosin 
glycosyltransferase 3 
(Ext3) 600209 Ext2 
type 3 multiple exostoses 
(600209?) 
glycosyltransferase 
(repeating HS 
disaccharide) HSPG cartilage, bone 
Chondroitin sulfate 
synthase 1 (Chsy1) 608183 
Chondroitin synthase 
1 (Css1); 
Carbohydrate synthase 
1; KIAA0990; Tbps 
Tentamy preaxial 
brachdactyly syndrome 
(605282) 
galactosyltransferase 
(repeating CS 
disaccharide) CSPG 
craniofacial, 
digits, teeth, 
brain 
Carbohydrate 
sulfotransferase 14 
(Chst14) 608429 
Dermatan-4-
sulfotransferase 1 
(D4st1); N-
acetylgalactosamine 4-
O sulfotransferase; 
Atcs; Edsmc1; Hnk1st 
type 1 
musculocontractural 
Ehlers-Danlos syndrome 
(601776) 
sulfotransferase (4-O 
position of dermatan 
GalNAc) DSPG 
craniofacial, 
digits, joints, 
vertebrae, 
muscle, skin, 
brain 
Carbohydrate 
sulfotransferase 3 
(Chst3) 603799 
Chondroitin 6-
sulfotransferase 
(C6st); Hsd; Gst0 
spondyloepiphyseal 
dysplasia with congenital 
joint dislocations 
(143095) 
sulfotransferase (6-O 
position of 
chondroitin GalNAc) CSPG 
bone, joints, 
heart 
Galactosamine-6-
sulfate sulfatase 
(Galns) 612222 
N-
acetylgalactosamine-
sulfate-sulfatase; 
Mps4a; Gas; 
Galnac6s; Galn6s 
type IVa 
mucopolysaccharidosis 
(253000) 
sulfatase (6-O 
position of GalNac) CSPG bone, teeth, eye 
Arylsulfatase b (Arsb) 611542 G4s; Mps6; As1 
type VI 
mucopolysaccharidosis 
(253200) 
sulfatase (4-O 
position of GalNAc) CSPG 
bone, liver, 
spleen, joints, 
eye, heart, 
craniofacial 
Arylsulfatase e (Arse) 300180 Cdpx 
X-linked recessive 
chondrodysplasia 
punctata 1 (302950) sulfatase  
craniofacial, 
digits 
9 
Iduronate 2-sulfatase 
(Ids) 300823 Mps2; Sids 
type II 
mucopolysaccharidosis 
(309900) sulfatase  
brain, nerves, 
craniofacial, 
heart 
Beta-galactosamine 1 
(Glb1) 611458 
Elastin-binding 
protein (Ebp); S-Gal; 
Elastin receptor 1 
type IVb 
mucopolysaccharidosis 
(253010); types I, II, and 
III GM1 gangliosidoses 
(230500, 230600, and 
230650, respectively) glycosidase CSPG 
nerves, liver, 
spleen, 
craniofacial, 
bone, eye 
Beta-glucuronidase 
(Gusb) 611459  
type VII 
mucopolysaccharidosis 
(253220) glycosidase  
brain, 
craniofacial, 
liver 
Family with sequence 
similarity 20, member 
c (Fam20c) 611061 
Dentin matrix protein 
4 (Dmp4) 
Raine syndrome 
(259775) kinase  bone 
Dermatan sulfate 
epimerase (Dse) 605942 
Squamous cell 
carcinoma antigen 
recognized by T cells 
2 (Sart2) 
type 2 
musculocontractural 
Ehlers-Danlos syndrome 
(615539) sugar epimerase DSPG 
joints, skin, 
muscle, 
craniofacial 
 
Other PG diseases in human specifically affect the eye and the brain, both of which are 
PG-rich (Ashworth et al., 2006; Avram et al., 2014; Shapiro et al., 2015). Mutations in the 
core proteins Versican, Decorin, Impg1, Impg2, Keratocan, and Nyctalopin (MIMs 
118661, 125255, 602870, 607056, 603288, and 300278) respectively cause eye defects in 
Wagner vitreoretinopathy, congenital stromal corneal dystrophy, vitelliform macular 
dystrophy 4 and 5, retinitis pigmentosa 56, cornea plana 2, and type 1A congenital 
stationary night blindness. Eye defects in macular corneal dystrophy types 1 and 2 are 
associated with mutations in the PG posttranslational modifier Chst6 (MIM 605294). PG 
diseases that affect the brain include congenital myasthenic syndrome 8, autosomal 
recessive mental retardation 46, mucopolysaccharidosis (MPS) types IIId and IIIa, and 
multiple sulfatase deficiency; these diseases are associated with respective mutations in the 
PG pathway members Agrin, Ndst1, Gns, Sgsh, and Sumf1 (MIMs 103320, 600853, 
607664, 605270, and 607939).  
  Since cartilage contains massive amounts of a class of PGs called chondroitin sulfate PGs 
(CSPGs), mutations to proteins involved in CSPG synthesis or modification often affect 
cartilage (and associated bone). The abundant cartilage core protein Aggrecan alone, for 
example, is mutated in three discrete cartilage diseases: Aggrecan-type 
spondyloepimetaphyseal dysplasia, Kimberley type spondyloepiphyseal dysplasia, and 
osteochondritis dissecans, short stature, and early-onset osteoarthritis (Lauing et al., 2014; 
Stattin et al., 2010). The CSPG posttranslational modifiers Galns, Glb1, and Arsb cause 
skeletal defects in MPS IVa, IVb, and VI when mutated (Table 2.1). The MPSs are a family 
of disorders that are linked to the breakdown of PGs, and they interfere with normal skeletal 
development (Lampe et al., 2013; Muenzer, 2011). For instance, MPS IV and VI are 
progressive diseases that cause major stunting of the skeleton and abnormal bone shape 
(Montano et al., 2007; Valayannopoulos et al., 2010). In addition to MPS IVb, mutations 
to Glb1 also cause types 1, 2, and 3 GM1 gangliosidoses, which are characterized by 
skeletal defects (Table 2.1).  
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Affecting about 50% of people over 60 years of age, osteoarthritis is a complex disease 
that is often characterized by loss of sulfated PGs in articular cartilage, leading some to 
suggest that mutations to PG-related genes might be causative. Indeed, Chst11, Xylt1, 
Xylt2, and Aspn, have been associated with osteoarthritis in genome-wide association and 
functional studies (arc et al., 2012; Schon et al., 2006; Valdes et al., 2007), but most of the 
statistical support for these and other genes is rather weak. The fact that osteoarthritis is a 
late-onset disease might be explained by two genetic hypotheses, which are not mutually 
exclusive. First, a large combination of genes might predispose to osteoarthritis, but the 
disease state only manifests after several decades of poor combined gene activity. Second, 
age-related epigenetic changes in chondrocytes might cause certain alleles to lose the 
ability to maintain articular cartilage homeostasis. Two recent large cohort studies, the 
Rotterdam study and stage 1 of the arcOGEN study did not find support for the polygenic 
hypothesis (reviewed in (Reynard and Loughlin, 2012). Therefore, future experiments are 
needed to test alternative hypotheses for the genetic causes of osteoarthritis. 
Two final considerations of the genetic basis of PG diseases need mention: genetic 
redundancy and hypomorphic alleles. Most components of the PG synthesis pathway 
appear to demonstrate some degree of genetic redundancy, so it is interesting that mutations 
to only one gene can cause disease (Table 2.1). The fact that most PG diseases specifically 
affect tissues, such as cartilage, bone, eye, and brain, with abundant PGs suggests that the 
levels of PG synthesis in a given tissue dictate that tissue’s susceptibility to disease when 
PG enzymes are mutated. From the other perspective, mutation to a single PG synthesis 
gene appears to be tolerated by many cells in the body. Another genetic issue related to 
levels of PG production is hypomorphism, which is to say that mutations associated with 
PG disease might not be null alleles, or complete losses of protein function. In fact, a few 
studies have shown residual enzyme activity in alleles of PG genes known to cause human 
disease (Baasanjav et al., 2011; Cortes et al., 2009; Dennis et al., 2009). The relatively 
minor decrease in overall levels of PG production observed in human disease likely reflects 
embryonic lethality in the case of complete loss of the PG synthetic pathway, but genetic 
experiments in animal models, such as zebrafish, could shed light on these open questions. 
2.1.3 Pas de deux: Biochemistry and cell biology of PG synthesis 
 
The array of enzymes that modify core proteins during PG synthesis is staggering, but this 
section highlights some interesting tricks that seem to have evolved to facilitate quality 
control. First, protein-protein interactions among enzymes are critical. For instance, the 
formation of multi-enzyme complexes is thought to allow the core protein to be modified 
sequentially, similar to an assembly line (Izumikawa et al., 2008; Mikami and Kitagawa, 
2013). Also, later modifications appear to be coordinated through enzyme cooperativity 
(Izumikawa et al., 2007; Kitagawa et al., 2003; Kitagawa et al., 2001). Second, different 
stages of core protein post-translational modifications are confined to discrete cellular 
compartments. For example, the first sugars are added in the endoplasmic reticulum (ER) 
and cis Golgi, the next set of sugars are added in the trans Golgi, and sulfation of these 
sugars happens in the trans Golgi and perhaps even further in secretory vesicles (Fig. 2.1; 
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Figure 2.1 The cell biology of sulfated PG synthesis and degradation.  
Below dashed line: schematized linker region of a CSPG showing specific sugars and post-translational modifications (while all 
possibilities of sulfation are shown, typically only certain sugars are sulfated at a given time). Above dashed line: CSPG components 
are color-coded with the schematic diagram to illustrate where each post-translational modification of the PG core protein occurs in 
the cell. In the linker region, most sugars and their modifications are added in the ER and cis Golgi. In the repeating disaccharide 
region, most sugars and their modifications are added in the medial and trans Golgi and secretory vesicles. Most sulfatases act on 
sulfated CSPGs in the lysosome during degradation, but some cell-surface/extracellular CSPG sulfatase activity may occur. 
Abbreviations: ER=endoplasmic reticulum; Gal=galactose; GalNAc=N- acetylgalactosamine; GlcA=glucuronic acid; Ser=serine 
residue on core protein; Xyl=xylose; 2-P=phosphorylation at 2-position of sugar ring; 2-S=sulfation at 2-position of sugar ring; 4-
S=sulfation at 4-position of sugar ring; 6-S=sulfation at 6-position of sugar ring. 
 
 
Figure 2.1 Schematic of the idea that cartilage PGs regulate GF signalling.Figure 2.2 The cell 
biology of sulfated PG synthesis and degradation.  
Below dashed line: schematized linker region of a CSPG showing specific sugars and post-translational modifications (while all 
possibilities of sulfation are shown, typically only certain sugars are sulfated at a given time). Above dashed line: CSPG components 
are color-coded with the schematic diagram to illustrate where each post-tranFigure 3 XRF and mid-IR maps can 
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(Calabro and Hascall, 1994; Doms et al., 1989; Fransson et al., 1992; Klausner et al., 1992; 
Lippincott-Schwartz et al., 1989; Spiro et al., 1991; Sugumaran et al., 1992; Uhlin-Hansen 
and Yanagishita, 1993; Yanagishita, 1993b). These latter studies suggest the interesting 
hypothesis that the genetics of PG synthesis might be linked with cell secretion pathways. 
Skeletal cells are prime candidates for elucidating such a relationship, given the massive 
amounts of PG synthesis inherent in their differentiation. However, only a few reports have 
addressed the importance of components of the secretory pathway on skeletal tissue 
formation (Knapik et al., 2014; Lang et al., 2006; Melville et al., 2011; Sarmah et al., 2010; 
Unlu et al., 2014), so this is a critical area of future research. Finally, studies of human 
disease implicate PG sulfation with another cell biological process: lysosomal degradation 
(Diez-Roux and Ballabio, 2005; Khatri and Schipani, 2008). Therefore, PG synthesis may 
interact genetically with many basic cell biology pathways. To aid in these future studies, 
we correlate in this section the biochemistry of PG synthesis with cell biology, concluding 
with an explanation of why some PG defects have dramatic effects on cell biology. 
 
2.1.4 Xylose: Where the “proteo-” meets the “-glycan” 
 
PG synthesis occurs in many ordered steps, beginning with core protein translation and 
translocation via its signal sequence to the ER (Vertel et al., 1993). Once in this cellular 
compartment, core proteins becoming CSPGs or HSPGs have the first sugar, xylose (Xyl), 
added to a specific serine (Ser) residue within a core protein consensus sequence, although 
this can also occur in vesicles near the ER and in the early Golgi compartments (Fig. 2.1; 
(Kearns et al., 1993; Vertel et al., 1993). Then, the nascent PG is shuttled to the cis Golgi 
network, where three more sugars are added, initiating the GAG sidechain of CS or HS 
with a typical O-linked tetrasaccharide linker region (Kearns et al., 1991; Kearns et al., 
1993; Vertel et al., 1993). Specifically, two galactose (Gal; not galactosamine) and one 
glucuronic acid (GlcA) residues are added to yield Ser-O-
Xylβ1(1→4)Galβ(1→3)Galβ(1→3)GlcAβ, where 1→3 or 1→4 represents the carbon 
positions on the sugar involved in the glycosidic bond (Fig. 2.1). The addition of each 
monosaccharide is catalyzed by a particular glycosyltransferase, starting with the Xyl 
addition by a Xylosyltranferase (Xylt), followed by two Gal additions by a β1, 4-
Galactosyltransferase I (B4galt) and a β1, 3-Galactosyltransferase II (B3galt), respectively, 
and finally GlcA addition by a β1,3-Glucuronyltransferase I (B3gat) (Mikami and 
Kitagawa, 2013). The efficiency of this process is thought to be increased by the formation 
of these linker region glycosyltransferases into a large, multi-enzyme complex, where each 
enzyme transfers its sugar, and then passes the substrate to an adjacent glycosyltransferase 
(Izumikawa et al., 2008; Mikami and Kitagawa, 2013). Even though CS and HS share the 
same tetrasaccharide linker region, they subsequently differ in the addition of a fifth 
residue: GalNAc or GlcNAc, respectively (Prydz, 2015; Sugumaran et al., 1992). In this 
way, the class of PG is determined before it moves beyond the cis-Golgi network. 
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The spatiotemporal sequence of events during PG linker region synthesis was visualized 
by electron microscopy and functionally confirmed using a compound called brefeldin A 
(BFA; reviewed in (Prydz and Dalen, 2000). For example, initial debate over whether PG 
xylosylation occurred in the rough ER or Golgi resulted from different interpretation of 
subcellular fractionation studies of cartilage cells (Geetha-Habib et al., 1984; Hoffmann et 
al., 1984). A well-designed experiment combining autoradiography, electron microscopy, 
subcellular fractionation, and immunohistochemical staining showed exactly where 
xylosylation was taking place (Kearns et al., 1993; Vertel et al., 1993). Typical of biology, 
the results supported a combination of the two initial hypotheses. Xylosylation occurred in 
the rough ER, but it also happened in transport vesicles near the nuclear membrane, as well 
as in early Golgi compartments. Functional confirmation of these results came from a 
technique involving BFA, which interferes with anterograde fusion of Golgi vesicles, 
causing accumulation of products from the cis and medial Golgi into the ER, whereas trans 
Golgi products remain separated (Doms et al., 1989; Klausner et al., 1992; Lippincott-
Schwartz et al., 1989). BFA experiments confirmed that PG xylosylation did not happen 
in the trans Golgi (Calabro and Hascall, 1994; Doms et al., 1989; Fransson et al., 1992; 
Klausner et al., 1992; Lippincott-Schwartz et al., 1989; Spiro et al., 1991; Sugumaran et 
al., 1992; Uhlin-Hansen and Yanagishita, 1993). Similar experiments revealed the 
regulation of PG sugar addition in discrete compartments of the cell secretory pathway 
(Fig. 2.1; (Campbell and Schwartz, 1988; Geetha-Habib et al., 1984; Kimura and Ichihara, 
1994; Lohmander et al., 1986; Ratcliffe et al., 1985; Sugumaran and Silbert, 1991; Vertel 
and Barkman, 1984; Vertel and Hitti, 1987). 
The precursors utilized by PG glycosyltransferases are actually nucleotide (specifically 
uridine diphosphate, or UDP) sugars, all derived from UDP-glucose (Lennarz, 1980; 
Neufeld et al., 1958). For example, Ugdh converts UDP-glucose to UDP-glucuronic acid, 
which is converted to UDP-xylose by Uxs1 (Oka and Jigami, 2006). High levels of UDP-
xylose can inhibit its own conversion, thus limiting itself in a negative feedback loop 
(Schwartz, 2000). Regulating the import of nucleotide sugars into Golgi vesicles is another 
control mechanism that links the rate of PG synthesis to resource availability. For instance, 
UDP-galactose is epimerized from UDP-glucose by Gale in the cytosol (Roper et al., 
2005), and then specific UDP-galactose transport proteins regulate levels of UDP-
galactose in the Golgi apparatus, thus limiting their availability for synthesis of the PG 
linker region (Toma et al., 1996). As might be expected, many components of this basic 
arm of the PG synthesis pathway are highly conserved from eukaryotes to prokaryotes 
(Eames et al., 2010).  
In addition to limited UDP-sugar availability, linker tetrasaccharide synthesis is regulated 
by phosphorylation of serine-linked Xyl in the nascent GAG sidechain, which is carried 
out by the kinase Fam20b (Fig. 2.1; (Koike et al., 2009)). While this 2-O-phosphorylation 
is required for efficient addition of the next two linker sugars by B4galt7 and B3galnt6, 
respectively, rapid dephosphorylation of Xyl occurs after GlcA addition (Moses et al., 
1997). Recently, the relevant phosphatase was identified (Koike et al., 2014). Untimely 
Xyl dephosphorylation can signal Extl2 to cap the linker region with an α-1, 4 GalNAc 
residue, which acts as a negative regulator since this capped pentasaccharide is no longer 
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able to serve as an acceptor for GAG biosynthesis (Mikami and Kitagawa, 2013). These 
data demonstrate that phosphorylation of Xyl is critical in ensuring an adequate number of 
tetrasaccharide primers are available during CS or HS synthesis, otherwise defective PG 
synthesis occurs (Eames et al., 2011; Wen et al., 2014).  
Sulfation of linker sugars is the other important modification that regulates PG linker 
region synthesis. Sulfation of Gal residues in the linker region can actually determine 
whether the GAG sidechain is CS or HS. HS never has sulfur modifications of these linker 
sugars, while CS and DS are commonly sulfated at one or both Gal residues (Laremore et 
al., 2007). These observations are more than a coincidence, since sulfation at the 6 position 
of the first galactose (Gal1) greatly increases activity of enzymes that initiate the repeating 
GAG region, while 4,6-disulfation of Gal2 or 4-sulfation of Gal1 can completely inhibit 
this activity (Gulberti et al., 2005). However, a later study by the same group showed that 
sulfation in the linker region only had positive effects on the activity of subsequent 
glycosyltansferases (Gulberti et al., 2012). Therefore, the exact role of sulfation in the 
linker region is unclear, but the sulfation of Gal residues in the linker region can influence 
subsequent glycosyltransferase activity, even specifying the type of GAG chain produced. 
 
2.1.5 Adding sugar like a kid after Halloween 
 
After establishment of the tetrasaccharide linker region, the repeating disaccharides that 
are characteristic of the HS and CS GAG sidechains are added by specific 
glycosyltransferases in the cis, medial, and trans Golgi compartments, respectively (Fig. 
2.1; (Dick et al., 2012). The repeating disaccharide of HS is added by Exostosins, mutations 
of which cause multiple hereditary exostoses (Kobayashi et al., 2000; Wuyts et al., 1998). 
Since their activities and regulation have been reviewed extensively (e.g., (Bernfield et al., 
1999; Esko and Lindahl, 2001; Lin, 2004; Tumova et al., 2000; Turnbull et al., 2001), we 
focus on control of repeating disaccharide addition in CSPGs. 
Six known glycosyltransferases catalyze synthesis of the repeating CS disaccharide (-
GlcA-GalNAc-), the length of which is regulated by cooperativity among some of these 
enzymes. Initial characterizations of their in vitro activity designated these six as the 
Chondroitin sulfate synthases Chsy1 (formerly called Chsy, Css1, or Tpbs) and Chsy3 
(formerly called Chsy2 or Css3); the Chondroitin polymerizing factors Chpf (formerly 
called Chsy2 or Css2) and Chpf2 (formerly called Csglcat or Chsy3); and the Chondroitin 
sulfate GalNAc transferases Csgalnact1 (formerly called Chgn or Beta4galnact) and 
Csgalnact2 (formerly called Chgn2 or Galnact2; (Mikami and Kitagawa, 2013). The first 
four of these enzymes can catalyze both glycosyltransferase activities needed to synthesize 
a growing CS GAG. The ability of each of these enzymes alone to add GalNAc to the 
repeating disaccharide is very limited, but it increases dramatically when any two of these 
enzymes are co-expressed (Izumikawa et al., 2008; Kitagawa et al., 2003; Yada et al., 
2003). Therefore, cooperativity among these enzymes regulates CS chain elongation. 
Csgalnact1 and Csgalnact2, on the other hand, each can transfer GalNAc residues 
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efficiently to the linker and repeating disaccharide regions of the growing CS GAG when 
acting alone (Gotoh et al., 2002; Sato et al., 2003). Due to these independent activities, 
these enzymes are critical for initiating GAG sidechain growth, as well as determining the 
ultimate chain length (Mikami and Kitagawa, 2013; Uyama et al., 2002). In an 
experimental model of atherosclerosis, for example, CSPGs with unusually long chain 
length in the aorta were associated with increased Csgalnact2 expression (Anggraeni et al., 
2011).   
The number of CS GAGs attached to a core protein is another variable that seems to be 
regulated by glycosyltransferases. Loss of Csgalnact1 leads to a reduction in how many CS 
chains are produced (Ishimaru et al., 2014; Sato et al., 2011; Watanabe et al., 2010). 
Conversely, over-expression of Csgalnact1 in chondrosarcomas creates large CSPG 
aggregates with greater than the normal number of CS chains (Sakai et al., 2007). Thus, 
Csgalnact1 seems to control somehow the initiation of GAG synthesis based on the number 
of other CS chains attached to that particular core protein (Mikami and Kitagawa, 2013). 
The mechanism by which this occurs remains the subject of future research.  
 
2.1.6 Don’t be a quitter: Post-translational modifications of post-translational 
modifications  
 
Similar to regulation of the linker region, sulfation of specific atoms on sugar residues is 
another major mechanism of control for GAG elongation efficiency, chain length, and 
chain number during PG synthesis. Addition of these sulfate groups occurs in the medial 
and trans Golgi (Fig. 2.1; (Sugumaran et al., 1992)). Three positions on the repeating 
disaccharide of CSPGs can be sulfated in various combinations: the 4 and 6 positions of 
GalNAc and the 2 position of GlcA (technically uronic acid). The repeating disaccharides 
of HSPGs also can be sulfated on the 2 position of GlcA, in addition to the 3 and 6 positions 
of GlcNAc (Bowman and Bertozzi, 1999; Mikami and Kitagawa, 2013). We focus our 
discussion on the 4 and 6 sulfation of GalNAc, since they are more CSPG-specific, and 
HSPG sulfation has received more attention in the literature (e.g., reviewed in (Bernfield 
et al., 1999; Esko and Lindahl, 2001; Lin, 2004; Tumova et al., 2000; Turnbull et al., 2001). 
Historically, classes of chondroitin sulfate that corresponded to these sulfation patterns 
were isolated using fractionation, and the naming convention has changed only slightly 
since (Levene and La Forge, 1913). Chondroitin sulfate A refers to chondroitin-4-sulfate; 
Chondroitin sulfate B is no longer used because it referred to dermatan sulfate; Chondroitin 
sulfate C refers to chondroitin-6-sulfate; Chondroitin sulfate D refers to chondroitin-2,6-
sulfate; and Chondroitin sulfate E refers to chondroitin-4,6-sulfate.  
Also similar to the linker region, enzyme cooperativity serves as an important regulatory 
control for the sulfation of CSPGs. Three different sulfotransferases catalyze sulfation of 
the 4 position of GalNAc in CSPG GAGs: Carbohydrate (chondroitin 4) sulfotransferases 
Chst11 (formerly called C4st1), Chst12 (formerly called C4st2 or C4s2), and Chst13 
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(formerly called C4st3; (Hiraoka et al., 2000; Kang et al., 2002; Yamauchi et al., 2000). 
Chst9 (formerly called Galnac4st2) also can perform this function (Kang et al., 2001), but 
it has not been studied extensively with respect to CSPG synthesis. Chst11 appears to be 
the major sulfotransferase involved in CSPG synthesis (Hiraoka et al., 2000; Kang et al., 
2002; Mizumoto et al., 2009; Uyama et al., 2006; Yamauchi et al., 2000), because loss of 
Chst11 cannot be compensated for by over-expression of Chst12 or Chst13 (Hiraoka et al., 
2000; Kang et al., 2002; Mizumoto et al., 2009; Uyama et al., 2006; Yamauchi et al., 2000). 
4-sulfated GalNAc residues on the growing end of each CS chain are required for chain 
elongation, but these chains are only extended efficiently when catalyzed by Chst11, not 
Chst12 (Izumikawa et al., 2011). These and similar data suggested that a given 
sulfotransferase may have specific physical interactions with glycosyltransferases, an idea 
supported by many studies (Izumikawa et al., 2012; Schonherr et al., 1999). For example, 
Csgalnact2 over-expression increased the amount of CS produced in a manner that 
depended on Chst11, but not Chst12 (Izumikawa et al., 2011). Increased expression of both 
Chst11 and Csgalnact2 were observed in an experimental model of elevated CSPG 
production (Anggraeni et al., 2011). The fact that Csgalnact2 cannot catalyze GlcA 
addition in the repeating CS disaccharide indicates that the influence of Csgalnact2 and 
Chst11 on chain length determination must happen by enhancing chain elongation 
efficiency by other glycosyltransferases, such as Chsy1 or Chpf (Anggraeni et al., 2011). 
Techniques to visualize the organization of these enzymes in vivo would add tremendously 
to understanding how this complex process is spatially coordinated. 
A proposed difference between CSPGs of humans and other vertebrates relates to the exact 
position of GalNAc where the majority of sulfation occurs: the 6 position in humans versus 
the 4 position in all other vertebrates (Vynios, 2014). At least two sulfotransferases (Chst3, 
Chst4) can catalyze addition of a sulfate group to the 6 position of GalNAc in CSPGs, but 
the most relevant appears to be Chst3 (formerly called C6st1; (Uchimura et al., 2002; 
Yamauchi et al., 2000). Differing levels of 6-sulfated GalNAc among vertebrates may 
explain differing phenotypes when Chst3 is mutated. Humans with loss-of-function 
mutations in Chst3 can have severe chondrodysplasia (Table 2.1; (Thiele et al., 2004)) 
Chst3 loss-of-function mice, however, show no overt phenotype, aside from lower levels 
of excreted 4-sulfated GalNAc (and lower levels of naïve T-lymphocytes; (Uchimura et 
al., 2002). This specific example may reflect broader evolutionary trends, where clade-
specific GAG sulfation patterns can be selected, providing a robust set of molecules fine-
tuned for different purposes (Sugiura et al., 2012). 
The end of CSPG GAGs is marked by two characteristic sulfation events: 4,6-disulfated 
GalNAc and 2-sulfated uronic acid (GlcA) residues (Ohtake et al., 2005). Chst15 
(previously called Brag or Galnac4s-6st) catalyzes 6-sulfation of a 4-sulfated GalNAc, and 
Ust (previously called 2ost) sulfates the 2-position of GlcA (Ohtake et al., 2001; Ohtake et 
al., 2005). These marks are not actually unique to the non-reducing end of the CS GAG, 
since they are also found in the internal disaccharides, but they seem to be enriched in the 
last disaccharide. Disulfated GalNAc residues are greater than 60 times more abundant at 
the non-reducing end of some (but not all) CS chains (Midura et al., 1995). 2-sulfation at 
the end of CS chains is found nested within the sequence GalNAc(4,6-S)-GlcA(2S)-
17 
GalNAc(6S; (Kobayashi et al., 1999; Ohtake et al., 2005). Providing another example of 
the complex regulatory cascades governing PG synthesis, 2-sulfation greatly enhances the 
activity of Chst15, implying that 2-sulfation of uronic acid happens before the adjacent 
residue becomes di-sulfated (Ohtake et al., 2003). 
 
2.1.7 Break it down for me, fellas 
 
PG sulfation is an on-again, off-again affair, with sulfatases removing sulfate groups added 
by sulfotransferases. Based on sequence identity, there are at least seventeen human 
sulfatases, although two of these enzymes currently have undefined biochemical activities 
(i.e., Arsi, and Arsj) (Sardiello et al., 2005). Cellular localization of these sulfatases varies 
widely, which suggests differing substrates and functions. Many sulfatases are found 
predominantly in lysosomes and participate in the molecular degradation pathway (Arsa, 
Arsb, Arsg, Arsk, Ids, Sgsh, Gns, and Galns), while others are detected mainly in the Golgi 
(Arse), in the ER (Arsc, Arsd, Arsf, Arsi, and Arsj), or on the cell surface (Sulf1, Sulf2; 
(Diez-Roux and Ballabio, 2005; Wiegmann et al., 2013)). The two general classes, 
lysosomal and non-lysosomal, reflect the optimal activity of each enzyme at low or neutral 
pH, respectively (Diez-Roux and Ballabio, 2005). Each sulfatase demonstrates a surprising 
specificity for substrate recognition, and seven sulfatases are known to target sulfated 
GAGs (Ratzka et al., 2010). A given PG sulfatase is thought to remove sulfate groups from 
not only a specific sugar within a GAG chain, but a specific position on that sugar. For 
example, Gns is a sulfatase that removes sulfate from the 6 position of GlcNAc in HS 
(Rivera-Colon et al., 2012). The two known CS-specific sulfatases are Galns and Arsb, 
which remove sulfate groups from 4- and 6-sulfated GalNAc, respectively (Diez-Roux and 
Ballabio, 2005).  
Due to the association of sulfatases and MPS diseases (Table 2.1), the major cell biological 
role for these enzymes thus far is PG degradation. The MPSs are a family of disorders that 
are all linked to the breakdown of the GAG chains of PGs. MPS types IV and VI are caused 
by mutations to the CS-specific sulfatases Galns and Arsb, respectively (Morrone et al., 
2014; Tomatsu et al., 2005; Valayannopoulos et al., 2010). These diseases have major 
effects on cartilage-mediated skeletal growth, but they are characterized more generally as 
lysosomal storage diseases (Montano et al., 2007; Valayannopoulos et al., 2010). Sulfation 
of PGs may add a new layer of functionality, but it turns out that PG sulfation inhibits their 
degradation (Freeze, 2009). Careful study of sulfatase deficiencies, such as in MPS 
disorders, revealed that an inability to desulfate PGs leads to a block of autophagy and an 
inability to regulate PG levels (Opoka-Winiarska et al., 2013; Settembre et al., 2008).  
Surely, the presence of Galns and Arsb in lysosomes suggests their role in CS catabolism, 
but surprisingly little is known about this process (Mikami and Kitagawa, 2013). Recycling 
of CSPG-rich matrix is thought to occur constantly in growth plate chondrocytes through 
the process of microautophagy (Settembre et al., 2008). In the current model, CS chains 
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are endocytosed in autophagosomes, which fuse with lysosomes, where at least three sets 
of enzymes break down the GAGs, releasing monosaccharides for recycling (Yamada, 
2015). Endoglycosidases break down the repeating disaccharide chains into 
oligosaccharides of approximately 10 kDa, which are then cleaved into monosaccharides 
by exoglycosidases (Freeze, 2009; Prabhakar and Sasisekharan, 2006; Yamada, 2015). The 
sulfatases Arsb and Galns cooperate in this latter process, since exoglycosidases do not 
function well unless the terminal hydroxyl groups on oligosaccharides are unmodified by 
acetate, phosphate, or sulfate groups (Freeze, 2009). Interestingly, CS is passed in normal 
human urine largely intact, implying that a baseline level of excretion occurs that bypasses 
the energetically expensive breakdown of potentially recyclable chains (Lennarz, 1980).  
While the specific lysosomal exoglycosidases responsible for CS metabolism in humans 
have been understood for some time, the corresponding endoglycosidases have only been 
identified recently. Along with β-glucuronidase, Hexosaminidase A and B (HexA and 
HexB) carry out exoglycosidase activity on CS chains (Yamada, 2015). More recently, a 
long-appreciated family of endoglyosidases have emerged as major CS degradation 
enzymes. Despite their name, Hyaluronidases, including Hyal1, Hyal4, and Spam1 (a 
testicular hyaluronidase), actually show a greater hydrolytic activity towards CS than to 
HA (Mikami and Kitagawa, 2013; Yamada, 2015). 
Estimates of cartilage CSPG catabolism rates suggest the possibility of extracellular 
sulfatase activity, which is an interesting topic of future research. 35S labelling indicated 
that the average CS turnover rate is approximately sixteen days in adult rat costal cartilage 
(Bostrom, 1952). Regarding the main cartilage CSPG core protein, Aggrecan in human 
articular cartilage was estimated from amino acid racemization rates to have a half-life of 
about three years, although smaller Aggrecan fragments may persist for about twenty years 
(Maroudas et al., 1998). If GAG sidechains are turned over much more quickly than the 
core protein for cartilage CSPGs, then are there extracellular CS sulfatase and glycosidase 
activities? A few studies suggest that this might be a fruitful avenue of cartilage research. 
Some cells in the liver express the “lysosomal” CS sulfatase Arsb on their cell surface 
(Mitsunaga-Nakatsubo et al., 2009). Also, lysosomal enzymes are secreted and circulate 
through the bloodstream and may participate in catabolism after being endocytosed 
(Elvevold et al., 2008; Natowicz et al., 1979). The notion of extracellular CS breakdown 
would be analogous to demonstrated roles of sulfatases and glycosidases that catabolize 
HS and HA (Esko and Selleck, 2002; Hacker et al., 2005; Harada et al., 2009). 
Other key enzymes play a role in CS catabolism. An Aggrecan core protein with attached 
CS chains is too large to undergo endocytosis intact, so some degradation is thought to be 
required extracellularly (Vynios, 2014). Three classes of proteolytic enzymes in the 
extracellular matrix, including Matrix metalloproteinases (Mmp’s), A disintegrin and 
metalloproteinase with thrombospondin motifs (Adamts’s), and Calpains, can cleave 
Aggrecan, and thus are key regulators of CSPG turnover rates (Struglics and Hansson, 
2010; Troeberg and Nagase, 2012). Of course, the complexity of CSPG catabolism is 
considerable, so these positive regulators of cartilage PG turnover are counteracted by 
negative regulators. For example, a family of proteins called Tissue inhibitors of 
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metalloproteinases (Timp’s) can reduce both Mmp and Adamts activity in cartilage matrix 
(Vynios, 2014). The fragmented Aggrecan chains are internalized by the cell and directed 
to the lysosome for further proteolysis by Cathepsins, in addition to the degradation and 
recycling of GAG chains. 
 
2.1.8 Adding function to structure by understanding PG-loss animal models  
 
Our vertebrate cousin, the zebrafish, shares a remarkable conservation of gene function 
with humans. An example from skeletal studies is that mutations to the transcription factor 
Sox9 disrupt the ability to form cartilage in both zebrafish and human (Yan et al., 2002). 
As we discuss below, mutations to the PG synthesis enzyme Xylt1 were described first in 
zebrafish, and the exact same skeletal phenotype was published subsequently in the Xylt1- 
mouse (Eames et al., 2011; McCoy et al., 2012; Mis et al., 2014). In fact, innumerable 
studies over the past 20 years have supported zebrafish as a model for human development 
and disease (Ali et al., 2011; Zon, 1999), so here we discuss animal models of PG defects, 
focusing on the zebrafish. In particular, these studies illuminate an emerging hypothesis 
that, similar to HSPGs, CSPGs play a non-structural, biological role in growth factor (GF) 
signalling. This section highlights the powerful genetics and imaging capabilities of 
zebrafish in order to address the role of PGs in modulating GF signalling in developing 
skeletal tissues.  
 
2.1.9 The old PG: Just another blockhead 
 
PGs were characterized traditionally as passive, structural molecules, but work over the 
past 20 years has modified that notion tremendously. The structural role for PGs is 
exemplified best by the cartilage core protein, Aggrecan. Aggrecan self-assembles into 
large aggregate structures with the high-mass polysaccharide hyaluronic acid (aka 
hyaluronan) via link proteins (Hardingham and Fosang, 1995; Kiani et al., 2002). 
Hyaluronic acid, a repeating disaccharide of glucuronic acid and N-acetylglucosamine, is 
not a PG, since it has no core protein, making it unique amongst the secreted 
polysaccharides (Khatri and Schipani, 2008; Laurent and Fraser, 1992). Hyaluronic acid 
alone can have a mass as large as 20,000,000 Daltons, a sturdy substrate that can be bulked 
massively when linked with over one hundred Aggrecan molecules, each capable of being 
decorated with up to 100 CS and 60 KS chains (Kiani et al., 2002). This is where the 
“bottle-brush” metaphor for the structure of PGs comes from.  
Sulfation of PG sugars leads to the structural function of PGs. The amount of PG sulfation 
is thought to be directly proportional to how much water it absorbs, which imparts cartilage 
matrix with its characteristic compressive-resistant strength (Chahine et al., 2005). In 
addition, hydration of Aggrecan aggregates creates the gel-like environment typical of 
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cartilage, an amazing evolutionary feat that currently cannot be mimicked by modern 
engineering, since it gives articular cartilage a lower coefficient of friction than Teflon 
(Gupta et al., 1985). Recent work indicates that PG sulfation also regulates a non-structural, 
biological role for PGs, but first we review a series of genetic studies leading to this 
concept. 
 
2.1.10 PGs regulate the timing of skeletal development 
 
A biological role for sulfated PGs in skeletal development was suggested by a few different 
animal models. For example, we isolated and analyzed zebrafish mutants that were 
defective in cartilage and bone development from an ENU mutagenesis screen (Eames et 
al., 2011; Miller et al., 2007). A class of mutants appeared to have decreased Alcian blue 
staining of PGs in their cartilage matrix, which consists predominantly of CSPGs (Eames 
et al., 2010). Using RAD-mapping, then meiotic mapping and sequencing, mutations were 
identified in two genes, xylt1 and fam20b (Eames et al., 2011; Miller et al., 2007). Xylt1 
had been known from biochemical studies of the 1970s to initiate GAG sidechain additions 
to PG core proteins (reviewed above; (Schwartz, 1977), but no vertebrate models of Xylt1 
loss had been reported, so its in vivo role remained unproven.  
The function of Fam20b was completely unknown, but a poster presentation of our genetic 
findings suggesting that Fam20b was involved in PG synthesis led to its biochemical 
characterization (Eames et al., 2008). The ortholog of Fam20b in the Drosophila fruit fly, 
Four-jointed, is a kinase that phosphorylates the cadherin domains of planar cell polarity 
proteins (Ishikawa et al., 2008; Matis and Axelrod, 2013). Pioneering work by the 
Kitagawa lab showed that Fam20b also functioned as a kinase, phosphorylating xylose in 
the nascent GAG sidechain (Koike et al., 2009). Although Fam20 members might 
phosphorylate the amino acids of proteins directly (Tagliabracci et al., 2014), the 
combination of these findings raises the question of whether Fam20 kinases only 
phosphorylate xylosylated proteins. Indeed, another major player in the planar cell polarity 
pathway, Notch, is known to be xylosylated (Bakker et al., 2009; Lee et al., 2013). 
Considering these cumulative data placing Xylt1 and Fam20b in the PG synthesis pathway, 
quantitative biochemical analyses of xylt1 and fam20b mutant embryos confirmed that they 
had defects in PG synthesis (Eames et al., 2011). 
Analyses of zebrafish xylt1 and fam20b mutants revealed that PGs affect the timing of 
skeletal development. Specifically, cartilage PGs inhibit endochondral ossification, a 
process of bone formation involving a cartilage template that is subsequently replaced 
(Eames et al., 2003). A biological role for cartilage PGs was suggested by the fact that bone 
formation increased in the mutant perichondrium, the tissue layer surrounding the defective 
cartilage (Eames et al., 2011). The amount of perichondral bone observed in mutants 
appeared in the same location at later stages in wild types, prompting the idea that mutant 
bone formation was precocious. Leading to the hypothesis that PGs regulate the timing of 
endochondral ossification, mutants initiated perichondral bone and expressed molecular 
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markers of osteoblasts, or bone-forming cells, prior to wild-type siblings (Eames et al., 
2011). An important question remained: How do cartilage PG defects cause early 
perichondral bone formation? 
The key linking defects in cartilage PGs to adjacent bone formation is the known 
communication between chondrocytes and surrounding cells of the perichondrium during 
endochondral ossification. As wild-type chondrocytes undergo maturation, they signal to 
induce cells of the adjacent perichondrium to form bone (Eames et al., 2003; St-Jacques et 
al., 1999). Could decreased levels of cartilage PGs somehow cause early chondrocyte 
maturation and expression of perichondral bone-inducing genes? The transcription factors 
Sox9 and Runx2 are negative and positive regulators, respectively, of chondrocyte 
maturation (Eames et al., 2003; Eames et al., 2004). Indeed, expression of sox9a was 
decreased and runx2 transcripts increased in xylt1 and fam20b mutant chondrocytes (Eames 
et al., 2011). The inductive event for perichondral bone formation is mediated by Ihh, 
expressed in maturing chondrocytes and not in perichondrium (Long et al., 2004). Indeed, 
ihh transcripts were up-regulated early in xylt1 and fam20b mutant chondrocytes, and 
genetic epistasis experiments showed that ihha function was necessary for the early bone 
of these PG mutants (Eames et al., 2011). In accordance with the primary defect being in 
cartilage, both xylt1 and fam20b are expressed highly in chondrocytes, but at low or 
undetectable levels in perichondral osteoblasts (Eames et al., 2011). In total, these data 
argue strongly that decreased levels of cartilage PGs change chondrocyte gene expression, 
altering the timing of endochondral ossification.  
As a brief aside, the specific findings of these mutant fish support an old hypothesis for the 
etiology of osteoarthritis. Osteoarthritis is a complex disease, associated with defects in 
articular cartilage and many other tissues, including subchondral bone and the surrounding 
synovial tissues and fluid (Felson et al., 2000). The etiology of osteoarthritis is unclear, but 
an old hypothesis is that breakdown of cartilage is the primary defect (Pitsillides and Beier, 
2011). As summarized above, zebrafish models of PG loss not only support this hypothesis, 
but also add specific predictions. In xylt1 and fam20b mutants, the primary defect is PG 
synthesis, and these fish produce less cartilage PGs; as a result of this primary defect, 
chondrocyte gene expression is mis-regulated, some of which induce extra bone in adjacent 
tissues (Eames et al., 2011). In osteoarthritis, common diagnostics are loss of sulfated PGs 
in articular cartilage, mis-expression of chondrocyte gene expression (specifically mis-
expression of chondrocyte maturation genes in more superficial layers of articular 
cartilage), and extra bone (osteophytes) in adjacent tissues (Lindblad and Hedfors, 1987; 
Pullig et al., 2000). Therefore, the zebrafish studies predict that the primary defect in 
osteoarthritis is actually the loss of sulfated PGs, and these other diagnostic features are 
secondary consequences of PG loss. Careful sampling of early time points in experimental 
models of osteoarthritis could test this novel perspective on an old hypothesis. 
Other PG mutant animal models support a role for PGs in the timing of skeletal 
development. Similar to xylt1 and fam20b mutant zebrafish, both Xylt1 mutant mice and 
Aggrecan-deficient (nanomelic) chicks displayed premature Col10a1 expression and 
chondrocyte hypertrophy (Domowicz et al., 2009; Mis et al., 2014). All of these animal 
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models decreased levels of CSPGs, but did not abrogate their production. Equivalent 
phenotypes among these mutant zebrafish, chick, and mice confirm the evolutionary 
conservation of PG function during endochondral ossification, specifically supporting the 
idea that CSPGs normally delay endochondral ossification. Furthermore, these animals all 
showed dwarfism, suggesting that disruptions to the timing of endochondral ossification 
might cause dwarfism. Interestingly, many human PG diseases are characterized by 
dwarfism (Table 2.1), which might be attributed simply to defects in sufficient ECM 
secretion, but an alternative attractive hypothesis is that the timing of skeletal development 
is disrupted. 
The timing of endochondral ossification is also disrupted in animal models that result in 
almost complete loss of sulfated PGs. For example, Uxs1 is required to make UDP-xylose, 
the substrate for Xylt1, and in uxs1 null mutant zebrafish, col10a1 expression and 
perichondral bone formation is delayed (Eames et al., 2010). Also, Papst1 generates sulfate 
precursors required for PG sulfation, and papst1 mutant zebrafish show delayed or absent 
col10a1 expression and perichondral bone formation (Clement et al., 2008). Defects in 
growth plate characteristics of other animal models of sulfated PG loss are consistent with 
disrupted developmental timing, although temporal analyses were not reported (Cortes et 
al., 2009; Kluppel et al., 2005). Interestingly, ext2 mutant fish displayed delayed or absent 
col10a1 expression and perichondral bone formation (Clement et al., 2008; Wiweger et al., 
2014), suggesting that loss of cartilage HSPGs might have the opposite phenotype to loss 
of cartilage CSPGs. In general, these studies indicate that CSPG defects accelerate, 
whereas HSPG defects delay, endochondral ossification. By what molecular mechanism 
can cartilage PGs influence chondrocyte gene expression and developmental timing, and 
how might different classes of PGs elicit at times opposite effects? 
 
2.1.11 The new PG: Regulator of growth factor signalling 
 
Recently, non-structural roles for extracellular matrix molecules, such as PGs, have been 
elucidated (Fig. 2.2). As an example of how the surrounding extracellular matrix can 
impact gene expression in resident cells, PGs are known to modify growth factor (GF) 
signalling, which in turn regulates transcription (Kim et al., 2011; Schaefer and Schaefer, 
2010). Revelatory work in Drosophila genetics almost 20 years ago showed that PGs 
regulate bone morphogenetic protein (Bmp) signalling in vivo (Jackson et al., 1997). 
Subsequent studies have shown that PGs affect a broad array of GF signalling pathways, 
including all the major developmental GF families (e.g., Bmp, Fgf, Hh, Wnt; 
(Bhattacharyya et al., 2015; Choocheep et al., 2010; Cortes et al., 2009; Han et al., 2005; 
Kluppel et al., 2005; Settembre et al., 2008). The mechanism through which PGs affect GF 
signalling is through direct binding (Bernfield et al., 1999; Harada et al., 2009; Hintze et 
al., 2012; Khan et al., 2011; Ni et al., 2014; Palma et al., 2011; Sardiello et al., 2005). Most 
of these studies focus on the role of HSPGs in GF signalling, perhaps because HSPGs are 
present in high numbers on cell membranes of most cell types (Hacker et al., 2005). For 
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example, the original 
Drosophila study showed that mutations to Dally, an HSPG core protein similar to 
Glypican, disrupted imaginal disc patterning (Han et al., 2005; Jackson et al., 1997).  
The molecular mechanisms through which PGs regulate GF signalling include influences 
on GF-receptor binding and GF diffusion. In cultured primary mouse fibroblasts, Hh 
signalling is increased through direct binding of the ligand and the PG Hspg (previously 
known as Perlecan; (Palma et al., 2011). On the other hand, Vegf binding to its receptor is 
inhibited by the PG Decorin (Khan et al., 2011). Regarding GF diffusion, Wnt ligand 
distribution in the Drosophila imaginal disc is increased by the PG Dally (Han et al., 2005). 
Conversely, diffusion of an Fgf ligand is inhibited by binding to PGs (Harada et al., 2009). 
Figure 2.2  Schematic of the idea that cartilage PGs regulate GF signalling.  
When bound to GFs, GF receptors modify transcription factors via a signal transduction cascade to 
regulate gene transcription. PGs surrounding developing chondrocytes can modulate GF signalling, and 
the specific effects may depend upon both the GF and the class of PGs involved. As depicted, CSPGs 
may inhibit binding between GF and receptor, acting as a sink; while HSPGs might facilitate binding of 
the same GF to its receptor. 
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As these studies illustrate, the overall effect of PGs on GF signalling can be positive or 
negative, depending on the specific GF, receptor, PG, and tissue under study. Regarding 
the influence of the class of PG on GF signalling, a signalling role for CSPGs has not been 
studied as extensively as HSPGs. However, CSPG-rich cartilage matrix provides a unique 
opportunity to evaluate in vivo interactions between CSPGs and GF signalling.  
A few published studies demonstrate that CSPGs indeed regulate GF signalling in cartilage, 
but these reports suggest that molecular mechanisms of PG signalling might differ between 
CSPGs and HSPGs (Fig. 2.2). In 2005, a seminal study by Jeffrey Wrana and colleagues 
was among the first to analyze CSPG signalling in vivo, and they showed that CSPGs 
negatively regulated Bmp signalling (Kluppel et al., 2005). The notion derived from this 
finding was that cartilage CSPGs were a “sink”, binding up GFs, perhaps acting as a GF 
reservoir. This negative role is opposite to the positive role for HSPGs in Bmp signalling 
that had been reported initially in Drosophila (Jackson et al., 1997), drawing attention to 
the potential divergence in signalling function between HSPGs and CSPGs. Similar to the 
different effects of HSPGs on signalling of different families of GFs, CSPG effects also 
vary. In cartilage, for example, CSPGs might promote Ihh signalling (Cortes et al., 2009; 
Domowicz et al., 2009; Gualeni et al., 2010; Mis et al., 2014; Sohaskey et al., 2008), but 
inhibit Bmp or Fgf signalling (Choocheep et al., 2010; Kluppel et al., 2005; Settembre et 
al., 2008).  
Future studies assessing the role of PGs in GF signalling must be careful to evaluate the 
specificity of experimental perturbations employed. For example, do the approaches 
specifically affect HSPGs vs CSPGs, since they might have different functions? While 
many PG synthesis enzymes affect both HSPGs and CSPGs, other enzymes are dedicated 
to generating only one of those two classes of PG. For example, Ext2 and Chsy3 are 
exclusive to HSPG and CSPG synthesis, respectively (Holmborn et al., 2012; Kitagawa 
and Nadanaka, 2014). Also, enzymes that control PG sulfation, a post-translational 
modification that regulates PG function (Pitsillides and Beier, 2011; Valdes and Spector, 
2010), are specific to a given class of PG, allowing another level of specificity when 
analyzing the effects of sulfated PGs on GF signalling. In addition, none of the above 
animal model studies used tissue-specific methods of gene alteration, so it is unclear 
whether the phenotypes attributed to cartilage CSPGs are actually due to defects in other 
tissues. To avoid this complication, Gateway and CRISPR technologies (Hwang et al., 
2013; Kwan et al., 2007) can ensure tissue-specific genetic alterations. For example, many 
cartilage- and bone-specific drivers of gene expression have been identified in zebrafish 
(Dale and Topczewski, 2011; DeLaurier et al., 2010; Eames et al., 2013; Hammond and 
Moro, 2012).   
On top of affecting the structural role of PGs, sulfation influences binding affinities (and 
thus signalling activity) of GFs and is actually required for normal GF signalling in 
cartilage matrix (Cortes et al., 2009; Otsuki et al., 2010; Rosen and Lemjabbar-Alaoui, 
2010; Valdes and Spector, 2010). As reviewed above, PG sulfation is regulated genetically 
by an array of enzymes, including sulfotransferases and sulfatases, that add and remove, 
respectively, sulfate esters on specific sugar residues (Bandtlow and Zimmermann, 2000). 
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In fact, many of the studies on the signalling role of CSPGs originate from genetic 
perturbations to CSPG sulfation pathways (Bhattacharyya et al., 2015; Cortes et al., 2009; 
Gualeni et al., 2010; Kluppel et al., 2005; Melrose et al., 2012; Settembre et al., 2008; 
Sohaskey et al., 2008). Despite the importance of sulfation for PG function, our ability to 
visualize PG sulfation in situ is limited by detection methods that are either too indirect 
and non-specific (e.g., Alcian blue binding; (Clement et al., 2008)) or too specific (e.g., 
antibodies that recognize only certain chemical isoforms of sulfated PGs, such as anti-
chondroitin sulfate-4S; (Cortes et al., 2009)). Novel synchrotron-based imaging modalities 
to visualize sulfur in cartilage matrix might address this limitation. 
 
2.2 Here’s looking at you, PG 
2.2.1 XRF imaging  
 
X-ray fluorescence (XRF) imaging starts with X-ray bombardment of a sample whereby a 
core shell electron is stripped and an electron from a higher energy orbital fills this gap, 
releasing a photon with an exact energy characteristic of that specific element (Fahrni, 
2007). Synchrotron XRF imaging relies on very bright sources of X-rays provided by 
specialized synchrotron facilities, such as the Canadian Light Source 
(http://www.lightsource.ca/) or newly developed lab-based instruments. The advantages of 
synchrotron for XRF imaging are the small, very bright beam used, and the ability to detect 
low concentrations of elements, such are those typically present within biological samples. 
XRF originates when an X-ray beam hits a sample with sufficient energy to knock out a 
core electron from a given atom present in the beam path. The core ejected electron leaves 
a temporary low potential energy “hole”, which is filled in by an electron from a higher 
potential energy shell, releasing a fluorescent photon with energy equivalent to the 
difference between the higher and lower potential energy shells (Paunesku et al., 2006; 
Pushie et al., 2014). Of course, many atoms have their electrons knocked out in the X-ray 
path, generating a complex spectrograph of emitted photons. Since each element has a 
specific higher to lower shell electron transition state (K-edge), however, the contribution 
of each element can be differentiated from other peaks through the choice of proper filters 
(thin metal sheets used for the purpose of attenuating beam intensity) and detectors. In the 
most common type of detector, a silicon drift detector, each incoming fluorescent photon 
hitting the detector plate creates an electron hole pair which “drifts” towards the anode on 
a silicon chip, allowing a measurement sensitive to incoming photon energy (Pushie et al., 
2014). Measurement of fluorescent photons has a signal to noise advantage over other X-
ray techniques based upon absorption and is ideally suited to hydrated biological specimens 
(Fahrni, 2007). The technique of K-edge subtraction (mapping at an energy above and 
below a K-edge jump to work out elemental distribution) is technically challenging since 
this technique relies on knowing the concentration of the element of interest beforehand. 
Critically, XRF can reflect the concentrations of elements, enabling quantitative analyses 
of XRF data (de Jonge and Vogt, 2010; Sole et al., 2007; Twining et al., 2003). X-ray 
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energies used to probe the fluorescence of atoms have the ability to image all of the 
elements in the periodic table down to about the mass of phosphorus, and absorbance 
techniques make it possible to evaluate the elements below this cutoff (Paunesku et al., 
2006).  
XRF has been utilized for a long time by various chemistry disciplines, but its recent 
adaptation as an imaging technique holds great promise for efforts to bridge biological and 
chemical realms. The main boost to imaging has come from the development of the silicon 
drift detector, which allows hundreds of thousands to millions of photon counts per second. 
With this technology, mapping can be performed on a single section in a reasonable amount 
of time at a high resolution (though still frequently requiring hours per scan). XRF imaging 
reveals spatially resolved patterns of elemental distribution by rastering a tissue section 
through the X-ray beam and registering the number of individual photons reaching the 
detector across all energies or “channels” at each raster position (Pushie et al., 2014). For 
example, perichondral bone in a tissue section can be highlighted using XRF imaging of a 
channel selected for Ca, due to high levels of hydroxyapatite in mineralized tissue (Fig. 
2.3). In fact, as outlined above, data from each pixel includes information on the 
concentration of several elements simultaneously, which can be very useful. Since the 
advent of newer detector technology and wider adoption of these techniques by biologists, 
the number of publications retrieved from PubMed using the keywords ‘X-ray 
fluorescence’ and ‘Biology’ have grown dramatically (doubling between 2008 and 2014).  
Newer XRF imaging techniques resulted from the desire to elucidate not only the chemical 
elements of the sample, but also the specific chemical species of those elements. For 
example, chemical states of a number of biologically important forms of sulfur, such as 
sulfate esters or disulfides, can be discriminated through chemically-specific XRF 
(Koudouna et al., 2014; Pickering et al., 2009). XRF data is generated only from the 
electrons of elements that can be excited at or below the energy of the incoming beam, and 
the exact chemical form of an element determines the characteristic energies at which its 
electrons will be excited (Pushie et al., 2014). Therefore, repeated scans of the same exact 
region of a tissue section taken using different incident energies can be used to work out 
the contribution of each specific chemical form of a given element (Pushie et al., 2014). 
Redox chemistry can also be deduced in this manner. For example, the ratio of oxidized to 
reduced glutathione can be used to reflect levels of oxidative stress (Hackett et al., 2012; 
Rompel et al., 1998). Each atomic element is present in the many types of molecule that 
comprise various tissues, but the chemical conformation of that element typically varies in 
a molecule-specific way. Taking advantage of this principle, chemically-specific XRF 
provides up to sub-micrometer resolution of molecular features of biological tissues 
without the need for special labelling. The practical size limit for imaging is strongly 
dependent upon the sample thickness, since self-absorption of sulfur K-edge fluorescent 
photons by the sample itself limits the detection by a small beam size where the number of 
photons is also restricted (even with a super-bright source such as a synchrotron).  
As highlighted in this review, understanding of PG biology would benefit tremendously 
from XRF imaging. Importantly, the abundant secretion of extracellular matrix by skeletal 
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cells potentiates application of XRF to skeletal tissues. The concentration of sulfur present 
in cartilage PGs makes this tissue readily identifiable using XRF (Fig 2.3; (Althoff et al., 
1982; Cichocki et al., 1989; Reinert et al., 2002; Reinert et al., 2001). Discrete sulfur forms 
are distinguishable by chemically-specific XRF, and the major form of sulfur in cartilage 
should be a sulfate ester, which is added to GAG sidechains by sulfotransferases (Mikami 
and Kitagawa, 2013). Indeed, the first demonstration was recently published of total sulfur 
and sulfate esters in normal and PG-defective zebrafish cartilage, opening up novel lines 
of research that seek to correlate directly PG function with PG-dependent biological 
process in cartilage (Hackett et al., 2016). 
Figure 2.3 XRF and mid-IR maps can illustrate molecular features of developing cartilage. 
All images are from 10 mm thick longitudinal sections of a flash-frozen, cryo-embedded HH36 chicken 
humerus. (A-D) XRF maps were gathered at the VESPERS beamline at the Canadian Light Source (CLS), 
using different channels during the same scan. Running peripherally along the middle of the element is 
newly forming perichondral bone, which shows up very strongly in the Zn and Ca channels. The higher 
levels of S reflect sulfated PGs in both cartilage and bone. (E-G) Infrared images were obtained at the 
Mid-IR beamline at CLS. Integrating the area under the band for the C-H stretching bond region (2800-
3000 cm-1) represents mainly carbohydrates (E), while the area under the total amide I band (1600-1700 
cm-1) represents total proteins (F). A second derivative map of the 1656 cm-1 protein band after 
normalization to total C-H stretching (G) demonstrates a low amount of protein in cartilage relative to the 
high amount of total C-H bonds contributed from carbohydrates. Abbreviations: C, carbon; Ca, calcium; 
Cl, chlorine; H, hydrogen; S, sulfur; Zn, zinc. (See color plate). 
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2.2.2 FTIR imaging 
 
Fourier transform infrared (FTIR) imaging relies on the fact that most molecules absorb IR 
light, so complex absorption spectra can reveal information about the types of molecules 
in the probed sample (Baker et al., 2014). The common unit for specifying the energy 
probed in IR spectroscopy is wavenumber (cm-1), which is basically the number of waves 
in a specified distance. Several interesting regions within the IR spectrum are used for 
analyzing biological tissues, but the most widely applied is mid-IR between ~3500 and 700 
cm-1 (Movasaghi et al., 2008). Each molecule can absorb IR light in a number of different 
modes, including vibrational, rotational, and flexional, so complex spectra must be 
devolved using Fourier transform to reveal potential causative molecules (Baker et al., 
2014). Non-linear molecules with N atoms have 3N-6 degrees of vibrational freedom 
(Stuart, 2004), so in a molecule of 10 atoms joined by 9 bonds, for example, there are 24 
possible vibrational degrees of freedom, each absorbing a discrete amount of energy. 
Therefore, even relatively simple compounds, especially in the 1500-900 cm-1 (so-called 
“bio-fingerprint”) region, exhibit complex, unique IR absorption plots (Baker et al., 2014). 
Using this complexity to its advantage, FTIR can positively identify organic substances 
and polymers, since the spectra acquired are so complex that only identical compounds 
will produce an identical absorption plot (Chen et al., 2013; Verhoef et al., 2005; 
Zimmermann et al., 2015).  
FTIR imaging (also called “mapping”) is carried out by shining a polychromatic IR beam 
(covering the entire IR region of interest, such as mid-IR or far-IR) either through or even 
reflected off the sample of interest onto a detector. Similar to XRF imaging, this process is 
repeated in a raster scan to produce an image of the tissue section. Each pixel in the “image” 
represents the average amplitude (intensity) of absorption of all the molecules at a given 
frequency, frequency range, or ratio of frequencies (Baker et al., 2014). From these data, 
IR biomarkers can be identified by selecting a pixel or group of pixels containing a 
particular biological feature of interest, and comparing the spectra from those pixels with 
those from other regions. In this manner, FTIR complements metabolomic studies in cancer 
biology to validate quickly and inexpensively tumorigenic phenotypes when a gold 
standard is lacking (Derenne et al., 2014; Noreen et al., 2012). 
Of the wealth of FTIR data, only a few specific molecules can be associated with specific 
wavenumbers, but future work on this nascent application to biology may prove to be very 
productive. Experimentally, a molecule can be added or removed from a mixture, and 
multivariate analysis can be performed to identify diagnostic IR bands that covary with the 
presence or absence of that specific molecule (Chonanant et al., 2014; Kwon et al., 2014). 
In addition, proper normalization of data to account for local variations in sample thickness 
allows FTIR to be used as a quantitative tool (Petibois et al., 2008). As opposed to XRF 
imaging, however, FTIR is resolution-limited by the wavelength of light used, so resolution 
at the highest frequency used in Mid-IR runs into a limit at about 5 μm (Lasch and 
Naumann, 2006). Despite this limitation, distribution of PGs in cartilage matrix occurs on 
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a much larger scale, allowing their visualization and potential changes associated with 
pathological conditions, such as osteoarthritis (Fig. 2.3). 
 
2.2.3 Visualizing sugars in vivo 
 
The study of PG function in vivo took another leap forward with the advent of sugar 
visualization techniques. Using azide click chemistry, sugars incorporated into the GAG 
sidechains of PGs can be visualized in a dynamic fashion, not only revealing the location 
of specific PGs, but also showing the temporal turnover of GAGs in pulse-chase 
experiments (Flanagan-Steet and Steet, 2013; Laughlin et al., 2008). For example, HSPGs 
are labelled by injecting zebrafish embryos with Az-GlcNAc compounds, while CSPGs 
are labelled with Az-GalNac compounds. After the compounds are incorporated into 
developing tissues, they are converted to fluorophores in vivo by fluorescent click 
chemistry (Laughlin et al., 2008), and finally HSPGs and CSPGs are visualized by confocal 
imaging. More recently, modified sugars have been introduced similarly to block GAG 
synthesis, and to visualize mucin (O-linked) glycans (Beahm et al., 2014; Kramer et al., 
2015). The fidelity and efficiency of these approaches to PG labelling are being optimized, 
but the technical imaging advances reviewed here and highlighted in zebrafish studies 
mean the future is bright for PG research. 
 
2.3 Conclusion 
 
PGs are recognized increasingly as critical structural and biological factors in many tissues, 
and we review here studies that revealed specific roles for PGs in cartilage matrix. When 
secreted abundantly in the extracellular matrix, PGs impart cartilage with mechanical 
properties, such as compressive resistance and low friction, both of which are required to 
facilitate movement at articulating surfaces of skeletal joints. Recent studies on biological 
roles for a specific class of PG, CSPGs, on growth factor (GF) signalling in cartilage have 
added complexity to our understanding of cartilage PGs. In fact, many diseases associated 
with defects in PG synthesis might reflect biological, as opposed to structural, functions of 
PGs.  
Zebrafish is a unique experimental system to illuminate the role of cartilage PGs in GF 
signalling, due to the ease of combining in this model system novel imaging techniques 
with genetic techniques that can alter a specific class of PG in a specific tissue. Many of 
these techniques are innovative in the whole of biology, if not in their application to skeletal 
tissues. Using zebrafish to understand the genetic and molecular mechanisms by which 
PGs regulate GF signalling can impact and inform any therapeutic approach relying upon 
GF application. More generally, by identifying new functions of known PG synthesis 
genes, we might increase diagnostic and therapeutic targets for many diseases. 
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3.1 Abstract 
 
Cartilage plays an important biomechanical role within the skeleton in part due to the high 
degree of sulfated proteoglycans (PGs) present within the extracellular matrix (ECM). 
Exactly how PG sulfation levels are regulated, especially during cartilage development 
remains an open question. Changes to sulfur metabolism have been shown to alter normal 
skeletal development in the human mucopolysaccharidosis (MPS) disorders. Also, animal 
models containing under-sulfated PGs show stunted growth and early bone formation, 
suggesting that a correlation does exist between lowered levels of PGs in the ECM and in 
increased rate of cartilage maturation and early bone formation. New techniques, such as 
chemically specific X-ray fluorescence (XRF) imaging for sulfate esters, combined with 
Fourier transform infrared (FTIR) imaging to measure PG levels in the matrix can be used 
to discover if there is a connection between the distribution pattern of sulfur in the ECM 
and the maturation state of the underlying cartilage. Based on a trend noted in a previous 
XRF study in zebrafish, the hypothesis that we put forward is that sulfated PGs decrease 
in mature cartilage. From elemental and chemically specific XRF imaging, we showed that 
total sulfur, and specifically sulfate ester levels, decrease significantly in mature cartilage. 
An imaging strategy to measure PG levels directly with FTIR was carried out to determine 
if decreased sulfate esters were tied to PG losses, or if they were decreasing independently. 
The strategy used two marker bands at 985 – 1140 cm-1 and 1374 cm-1 (second derivative), 
which have been reported on previously. No significant change was observed for PG levels 
in mature cartilage according to this analysis for either band. We suggest that chondroitin 
sulfate (CS) PGs in mature cartilage are either losing sulfate esters directly from the ECM 
by an uncharacterized mechanism, or that they are differentially processed to contain less 
sulfur during turnover by pre-hypertrophic and hypertrophic chondrocytes. An 
understanding of how sulfur levels relate to differentiation states of chondrocytes could 
lead to new understandings for how sulfur may drive pathological states in cartilage.  
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3.2 Introduction 
 
Chondroitin sulfate (CS) proteoglycans are the most abundant proteoglycan (PG) found in 
both developing and persistent cartilage, though their function in the development of the 
skeleton is still not well understood. The anionic properties of highly sulfated PGs in the 
extracellular matrix (ECM) heavily influence the mechanical properties of cartilage. While 
collagen proteins provide tensile strength and cohesion to the ECM, CS chains rich in 
sulfate esters grant cartilage its incredible resistance to compressive loads by increasing 
hydrostatic pressure (Aumailley and Gayraud, 1998; Chahine et al., 2005). Unlike 
heparin/heparan sulfate proteoglycans, which are known to be involved in the normal 
maturation of the chondrocytes endochondral bone formation (Bernfield et al., 1999; 
Hacker et al., 2005; Lin, 2004; Tumova et al., 2000; Turnbull et al., 2001), CS sulfate 
molecules have received very little attention until recently about these same roles attributed 
to heparin/heparan sulfate because their main function is to provide structural support to 
cartilage.  
During endochondral ossification, cartilage acts as a biodegradable scaffold made up of 
chondrocytes at different stages of maturation, which are responsible for both the synthesis 
and degradation of the ECM. Immature chondrocytes appear after several longitudinal 
mitotic divisions of a proliferative chondrocyte which then begin to secrete large amounts 
of ECM composed of mainly Collagen type II (Col2) and Aggrecan. Aggrecan is the 
defining PG of cartilage and consists of its own core protein onto which is attached up to 
100 CS chains and a smaller number of keratan sulfate (KS) chains (Roughley and Mort, 
2014). As the cartilage element grows through appositional division and interstitial growth, 
pre-hypertrophic and hypertrophic chondrocytes (together termed mature chondrocytes) in 
the central region initiate matrix production focused on Collagen type 10 (Col10) 
(Vortkamp, 2000). The final stages of chondrocyte differentiation lead to the degradation 
of the ECM by matrix metalloproteinases, vascular invasion, and apoptosis of most mature 
chondrocytes – although direct transdifferentiation of chondrocytes to osteoblasts has been 
observed (Hinton et al., 2017; Karsenty and Wagner, 2002; Vu and Werb, 2000).  
The synthesis of CS glycosaminoglycan (GAG) chains (which are composed of glucuronic 
acid (GlcA) and N-acetyl galactosamine (GalNAc) disaccharide repeats) occurs in the ER 
and early Golgi compartments, and sulfation of the newly synthesized chondroitin chain 
happens concomitantly with the action of sulfotransferases (Brown and Eames, 2016). CS 
synthesis is initiated in the ER through xylosylation of a serine residue on the core protein, 
and synthesis of a tetrasaccharide linker region (xylose -galactose –galactose -
GlcA)(Schon et al., 2006). The determination of the GAG chain identity as either CS, 
keratan sulfate, or heparan/heparin sulfate is dependent on the initial sugar added to the 
tetrasaccharide linker. Polymerization of each GAG chain is carried out by the general CS 
polymerases GlcAT-II (GlcA transferase II) and GalNAcT-II (GalNAc transferase II) 
(Izumikawa et al., 2007; Kitagawa et al., 2003; Nadanaka and Kitagawa, 2008). Sulfate 
moieties are attached to growing CS chains in the form of O – linked sulfate esters. Sulfate 
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esters of CS can occupy the 4- and 6- carbons of the GalNAc sugar, or the 2-carbon of 
GlcA. CS GAGs are characterized starting out as an unsulfated O unit, and proceeding 
through either a 4-sulfation to yield an A unit, or initial 6-sulfation (C unit). CS A units 
commonly undergo additional 6-sulfation to yield a 4,6-sulfated disaccharide (E unit), and 
6-sulfated C units can undergo 2-sulfation of GlcA, forming a 2,6-sulfated D unit (Brown 
and Eames, 2016; Kusche-Gullberg and Kjellen, 2003; Uyama et al., 2007). Postnatally, 
CS molecules have roughly equal proportions of 4- and 6- sulfated disaccharides; however, 
this ratio changes from approximately 50 % to 80 % 6-sulfation through the course of 
ageing from birth to 20 years of age (Bayliss et al., 1999). Along with shifts in the 4/6 - 
sulfated GAG ratio during development, changes in Aggrecan substituent chain lengths 
also occur as part of normal human development, with increasing chain lengths for KS and 
decreasing lengths seen for CS until the age of 20 (Brown et al., 1998; Plaas et al., 1997; 
Roughley, 1987; Roughley and White, 1980).  
CS de-sulfation requires enzymes known as sulfatases which act on PGs during lysosomal 
degradation and which can affect growth plate dynamics. The family of known CS 
sulfatases includes three lysosomal enzymes, Arsb (EC 3.1.6.12; (Bhattacharyya et al., 
2015)) and Galns (EC 3.1.6.4; (Tomatsu et al., 2005)) which act on GalNAc-4-S and 
GalNAc-6-S, respectively)] and the recently characterized sulfatase ARSK (EC:3.1.6.-), 
which acts on the GlcA-2-S D-unit of CS, (Dhamale et al., 2017; Wiegmann et al., 2013), 
and is also thought to act in the lysosome. There also exist several predicted sulfatases with 
unknown substrate-specificity and functions, which could very well act as CS sulfatases 
(Ratzka et al., 2010). In human skeletal development, sulfur PG misregulation in the form 
of mutations to either ARSB or GALNS are the cause for the mucopolysaccharidosis (MPS) 
disorders MPS IV and MPS VI, respectively (Muenzer, 2011). Both conditions cause a 
range of stunting during skeletal development depending on the severity of the mutation 
(Montano et al., 2007; Valayannopoulos et al., 2010). The severe effects that these sulfatase 
mutations have on skeletal development suggest that they might cause a problem with the 
cartilage maturation process during endochondral ossification.  
Animal models of inherited diseases are invaluable tools in studying the specific genetic 
and biochemical etiology and prognosis of developmental disorders. Abnormal and stunted 
growth is characteristic of many animal PG mutant models, whether these mutations 
somehow affect PG synthesis, PG sulfation, or PG desulfation and degradation (Alliston, 
2010; Cortes et al., 2009; Domowicz et al., 2009; Khatri and Schipani, 2008). The primary 
disruptive cellular process of the MPS-VI disorder in the feline model of the disorder is 
thought to arise due to the accumulation of DS GAGs in the lysosome leading to cell 
enlargement, dysfunction, and apoptosis (Simonaro et al., 2001; Valayannopoulos et al., 
2010). Brd-U labelling has revealed that MPS cells divide up to 5 times faster than normal 
cells to offset high levels of apoptosis, such that the relative cell counts are the same in 
both cases (Simonaro et al., 2005). Despite similar cell counts in the growth plate, 
decreased bone growth in feline MPS-VI has been suggested to occur due to a slowed rate 
of hypertrophy (Nuttall et al., 1999). The absence of chick Aggrecan accelerates the 
process of cartilage maturation in the nanomelic long bone growth disorder (Domowicz et 
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al., 2009). Recent findings from zebrafish agree with conclusions from other studies on 
cartilage disorders in animal models, that the scarcity of the sulfated PG molecules within 
the ECM can have the opposite of delayed bone growth, that is, precocious bone 
development (Cortes et al., 2009; Domowicz et al., 2009; Eames et al., 2011; Hackett et 
al., 2016). The direct association between lowered PG levels and precocious bone 
formation is evidence that PG (and sulfation) levels are negatively related to the rate of 
cartilage maturation. The cartilage template relies on sulfated PGs to proceed through 
normal timing of growth and bone formation as evidenced by these mutant models. 
Evidence for the purposeful modulation of these levels by mature cartilage throughout 
development will come from studies of normal animal cartilage which will hopefully point 
to the exact mechanism or mechanisms responsible for these fine-tuned changes directing 
development. 
Chemically-specific X-ray fluorescence (XRF) imaging has recently emerged as a tool 
which allows the visualization of tissue wide patterns of sulfation, data that is lacking from 
previous biochemical techniques focused on overall analysis of cartilage PGs. In zebrafish, 
chemically-specific XRF imaging was used to quantify sulfate ester levels, the main form 
of sulfur in cartilage, in the cartilage deficient fam20b mutant (Hackett et al., 2016). 
Analysis of sulfate ester levels in wild-type zebrafish cartilage revealed that there may be 
a correlation between cartilage maturation state and overall sulfated PG levels in the 
matrix. Losses of sulfate ester signal from fam20b mutant zebrafish also strongly argue that 
the sulfate esters in the matrix come directly from sulfated PGs. Previous bulk analysis of 
sulfur in developing chicken cartilage using electron probe also showed a significant 
decrease in the sulfur content of mature cartilage (Hargest et al., 1985), but this was based 
on bulk analysis of total sulfur and did not address whether sulfate esters from PGs were 
specifically decreasing, nor did it reveal the spatial nature of how sulfur was distributed. 
Since the sulfate esters present in chicken are directly related to the sulfation of PG GAG 
chains, changes to the levels of sulfate esters within cartilage must reflect either a change 
in overall PG content, or a change in the sulfation level of the GAGs present. Changes to 
PG content in the ECM may reflect changes in individual PG chain lengths, or the total 
number of PG chains present. Fourier transform infrared (FTIR) imaging is another 
imaging based technique which has been used to quantitate overall PG levels in cartilage 
(Kim et al., 2005) and can be used to identify whether or not changes in PG levels are 
associated with changes in sulfate ester levels. 
The human MPS-IV and MPS-VI growth disorders are caused by a decrease in the ability 
of lysosomes to efficiently degrade PGs due to a loss of function of sulfatase enzymes. 
Other animal models for mutations involving CSPG sulfation and synthesis are the cause 
of even more severe and even earlier onset changes which directly affect the maturation 
rate of chondrocytes and lead to early bone formation (Cortes et al., 2009; Domowicz et 
al., 2009; Eames et al., 2011). To try to better understand the link between tissue-wide 
sulfation patterns and the state of the underlying chondrocytes, the hypothesis set forth in 
this study is that PG sulfate ester levels decrease in mature cartilage during development. 
Directly related to the observations regarding sulfation levels and changes to the maturation 
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rate of cartilage, we demonstrated that sulfate ester levels in mature chicken cartilage 
decreased significantly when compared to immature cartilage, while proteoglycan levels 
in mature cartilage did not decrease significantly. These findings together indicate that 
mature PGs are under-sulfated with respect to immature PGs, and one possibility for this 
decrease in sulfation might be substrate level desulfation of CS occurring in the ECM. 
 
3.3 Methods 
3.3.1 Animal Model 
White leghorn chicken eggs (N = 10) were incubated in a humidified, rocking incubator at 
37 °C until they reached Hamburger-Hamilton stage 36 (~10.5 days of incubation) 
(Hamburger and Hamilton, 1951). This work was approved by the University of 
Saskatchewan's Animal Research Ethics Board, and adhered to the Canadian Council on 
Animal Care guidelines for humane animal use. 
3.3.2 Sample preparation 
 
Each embryo was killed by decapitation following its removal from the egg onto an empty 
glass receiving dish. Chick forelimbs were collected by dissection in phosphate buffered 
saline followed by embedding in OCT compound (Tissue Tek, Torrance, CA, USA) and 
immediately flash-frozen in liquid nitrogen-cooled isopentane. Chick forelimbs used for 
imaging were all from different individuals. 10 µm-thick sections of the humerus were 
cryo-sectioned and collected onto metal-free plastic coverslips (Thermanox, Mississauga, 
ON, Canada) for XRF imaging, and sections being prepared for Mid-IR analysis were 
collected onto an IR-grade CaF2 window (Crystran, Dorset, UK). Eight to ten adjacent 
serial sections were collected onto Superfrost Plus™ glass slides (Fischer Scientific, 
Canada) for later immunohistochemistry (IHC) analyses or other potential applications, 
such as RNA in-situ hybridization analysis for looking at mRNA expression patterns. 
Sections imaged at the synchrotron were retained at -80 °C for later Safranin O staining.  
3.3.3 Histology 
 
For Safranin O tissue section staining, cryosectioned tissues were re-hydrated in water for 
1 minute before staining. Sections were placed in Wiegert’s hematoxylin for 5 minutes, 
rinsed in running tap water for 1 minute, and then counter-stained in fast green FCF (0.05 
%) for 1 minutes. The tissues were then de-stained in 1 % acetic acid for 10 dips. Sections 
were then left in 0.1 % safranin O stain for 20 minutes and then dehydrated and mounted 
with a coverslip and Permount™ (Fisher Chemical, Mississauga, ON, Canada). Alizarin 
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red and Alcian blue whole mount staining on HH36 chick humeri was performed as 
previously described (Eames et al., 2011). 
3.3.4 Pink-beam XRF at VESPERS 
 
XRF imaging of total sulfur was performed at the Very Sensitive Elemental and Structural 
Probe Employing Radiation from a Synchrotron beamline at Canadian Light Source 
(VESPERS) beamline at the CLS. VESPERS is a bend magnet beamline which uses a Si 
(111) crystal monochromator pair and Kirkpatrick-Baez focusing mirrors (minimum 2  4 
µm spot size) with several bandpass modes available. The detector used for fluorescence 
imaging was a Vortex®-ME4 4-element dispersive silicon drift detector (Hitachi, Troy, 
MI, USA). Each humerus sample on Thermanox™ was mounted vertically, inclined 45° 
relative to the incoming beam. Each humerus was raster-scanned with a 15  15 µm step 
size using 4  6 µm (horizontal  vertical) sized pink beam (15 keV excitation) with a 1 
second dwell time for each pixel for the purpose of capturing data for multiple elements 
other than sulfur. Each humerus was approximately 3000  4000 µm in size resulting in 
approximate scan times of 7 hours. Upstream filters were used to cut down on incoming 
signal intensity reaching the detector to minimize dead-time effects. In total, 10 humerus 
samples were measured in this way at this beamline. 
3.3.5 XANES data collection at the Canadian Light Source SXRMB beamline 
 
X-ray absorption near-edge spectroscopy (XANES) spot scans were taken at SXRMB to 
determine all of the constitutive forms of sulfur present in mature and immature cartilage. 
X-ray absorption spectroscopy was carried out at the Soft X-ray Microcharacterization 
Beamline (SXRMB) at the CLS, where low energy X-rays are employed for observing the 
K-edges of lighter elements, particularly sulfur and phosphorus. Prior to the collection of 
spectra, the sample chamber was purged with He until the relative O2 content within the 
chamber was <0.5%. XANES spectra were calibrated against the spectrum of an anhydrous 
Na2S2O3 powder solid standard, with the lowest-energy peak thought to be 2469.2 eV, as 
described previously (Gnida et al., 2007; Pickering et al., 2001; Pickering et al., 1998; 
Pickering et al., 2009; Sekiyama et al., 1986). Spectra were collected across the energy 
range of 2450–2515 eV, with a total collection time of approximately 10 min, using the 
Acquaman software package  
(http://beamteam.usask.ca/mark/acquaman/index.html). Each spot scan measurement was 
taken as the averaged spectra of three replicate measurements at each spot. Spot scans were 
collected for at least 3 spots in the immature cartilage region and at least 3 spots in the 
mature region. The error for each measurement represents the standard error of the mean 
for each compound based on individual fittings. One sample out of four measured for 
XANES fitting in total was removed as an outlier because the sulfate ester and sulfonic 
acid percent fits were very different from the others. Spectra of calibration standards and 
model compounds were recorded at room temperature. Powdered solid standard 
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compounds used for fitting routines represented disulfides (oxidized glutathione), thiols 
(reduced glutathione), thio-ethers (methionine), sulfoxides (methionine sulfoxide), sulfinic 
acids (hypotaurine), sulfonic acids (taurine), O-linked sulfate esters (N-acetyl D-
galactosamine 6-sulfate), N-linked sulfate esters (D-galactosamine 2-sulfate), and 
inorganic sulfates (Na2SO4). Spectra were collected from a total of four samples from 
different specimens. The number of spots used was not enough for a statistical comparison 
to be made between regions, since when directly comparing measurements, the individual 
measurement errors must be added together, resulting in error values which are bigger than 
the differences between regions for all of the forms of sulfur measured.  
3.3.6 Chemically-specific XRF imaging at SXRMB 
 
Chemically specific imaging of sulfate esters and sulfonic acids was performed at the 
SXRMB beamline at CLS. To create maps of sulfate esters and sulfonic acids, three XRF 
maps at different energies in the sulfur K-edge region and one map of total sulfur were 
created and processed as previously described (Hackett et al., 2016). The beamline relies 
on a bending magnet source, and operates in the 1-10 keV range with an energy resolution 
ΔE/E of 1.0 × 10-4. Energy calibration was performed using a powder on tape standard 
composed of sodium thiosulfate placed in the ambient chamber in electron capture mode. 
Monochromator motors were calibrated at the start of each session. Humerus samples were 
mounted on an aluminum sample holder using carbon tape. Samples were mounted in a 
vacuum chamber with a 45° angle to the vertical plane relative to the incoming beam. The 
calibrated peak value of the secondary peak of sodium thiosulfate used at the SXRMB 
beamline is 2472.0, based on the value in the Handbook on Synchrotron Radiation 
published by the Lawrence Berkeley National Laboratory in 2011 (http://xdb.lbl.gov/). 
This calibration value is 2.8 eV higher than the energy used at SSRL, where the ideal peak 
fitting ratios were obtained solving for sulfonic acids and sulfate O – linked esters 
simultaneously. This may result in slightly off of white-line energies used for imaging, 
resulting in very slightly systematically shifted proportions of each of these two 
components from which the maps are derived. The four energies measured for chemically 
specific imaging at SXRMB were 2500.0 eV (for total sulfur) 2479.2 eV, 2477.6 eV and 
2474.4 eV. In total, 6 humerus samples were measured in this way at this beamline, all of 
which were also imaged at the VESPERS beamline for total sulfur and included in the XRF 
quantitation.  
3.3.7 Mid-Infrared (FTIR) Imaging 
 
Fourier transform infrared (FTIR) imaging is being rapidly adopted as a research technique 
for the non-perturbative and label free analysis of biological tissues (Baker et al., 2014). It 
is a promising tool for looking at spatial changes to PG content by using wavenumber 
ranges correlated with cartilage matrix CSPGs (Saarakkala and Julkunen, 2010). FTIR 
imaging was performed at the mid-IR beamline at the CLS. FTIR imaging was performed 
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to assess if there was also a trend in overall PGs observed between regions that could 
account for decreasing sulfate esters from the ECM. Three different IR regions of interest 
were focused on to determine the relative abundance of total proteins and CS proteoglycans 
in mature versus immature cartilage. Normalization of spectra is important for infrared 
imaging because it accounts for confounding factors, such as thickness variations, and 
because otherwise differences in absorbance intensities will be highlighted, rather than 
biological differences (Baker et al., 2014). Total protein content is commonly used to 
normalize spectra to account for variations in thickness (Baker et al., 2014). Protein was 
estimated using the amide I band arising from C=O stretching of peptide bonds. Two IR 
regions, 985 – 1140 cm-1 and the 1374 cm-1 second derivative band, were chosen to give 
independent estimates of CS content based on previously validated studies (Boskey and 
Pleshko Camacho, 2007; Kim et al., 2005; Saarakkala et al., 2010). 
All infrared data were collected with a Hyperion 3000 FTIR imaging system (Bruker 
Optics, Ettlingen, Germany) fitted with a mercury-cadmium-telluride (MCT) 64×64 focal 
plane array (FPA) detector with an upper objective of 15x magnification and a numerical 
aperture of 0.4, combined with a lower condenser of 15x magnification and 0.4 numerical 
aperture. This arrangement yielded a pixel size of 21.4 μm2, using 8x8 binning. All scans 
were performed in transmission mode. Samples were mounted on IR-grade CaF2 windows 
(Crystran Ltd.). A focal plane array detect was illuminated with a Globar source (aperture 
3.5 mm, part of the Hyperion 3000 FTIR system used). FTIR-spectroscopic images were 
collected across the spectral region 3600 – 900 cm-1, on a liquid nitrogen cooled focal plane 
array (FPA) detector with a spectral resolution of 4 cm-1 with the co-addition of 128 scans, 
with a background image similarly collected from blank substrate using 128 co-added 
scans. The background was collected immediately prior to each sample. In total, 8 humerus 
samples were measured in this way at this beamline. 
3.3.8 Immunohistochemistry  
 
COL10 IHC was performed on adjacent serial sections to those imaged at the CLS to 
visualize mature cartilage for drawing precise regions of interest used in subsequent 
quantitative analyses. Sections from storage at -80 °C were first adhered to glass slides by 
drying at 56 °C for 15 minutes. The sections were then post-fixed in 4 % PFA for 10 
minutes at room temperature. Slides were then rinsed twice in PBS. Blocking was carried 
for 1 hour in blocking solution (10 % sheep serum in PBS). After blocking, 100 µL of 
1:100 primary mouse α-COL10 antibody (X-AC9, Developmental Studies Hybridoma 
Bank (DSHB), Iowa City, IA) in dilution buffer (0.5 % sheep serum in PBS) was added 
and the slides were placed in an incubated chamber to rock at room temperature for 1 hour. 
The slides were then rinsed carefully in 2 changes of PBS for 5 minutes each. 100 µL of 
1:2000 fluorescent rabbit α-mouse antibody (Chemicon, Temecula California) in dilution 
buffer were then added and left to rock in a humidified chamber in the dark at room 
temperature for an additional 30 minutes. Slides were rinsed twice in PBS as before and 
40 
nuclei were then stained with Hoechst stain for 10 minutes in the dark before applying 
cover slips. 
3.3.9 Data processing and statistical analysis 
 
All XRF maps collected at SXRMB and VESPERS were first opened in Sam’s microprobe 
analysis toolkit (SMAK) version 1.40 (https://www.sams-xrays.com/smak) and 
normalized to the pre-sample ion chamber channel. To create chemically specific maps for 
sulfonic acids and sulfate esters, each map (e.g. 2500.0 eV, 2479.2 eV, 2477.6 eV and 
2474.4 eV) was first normalized to the incoming beam current. Each map was then 
imported into a single file and the 2474.4 eV channel (background) was subtracted from 
the 2479.2 eV and 2477.6 eV maps. The “X-ray absorption near edge structure (XANES) 
fitting” sub-program was used to create the sulfate ester and sulfonic acids maps using the 
peak ratio parameters of 4.8:4.1 and 1.27:5.6 for 2477.6 eV and 2479.2 eV (both 
background subtracted as previously mentioned), respectively, as determined by 
determined by XANES measurements of pure standard compounds (Hackett et al., 2016). 
While referencing the optical microscope image of the same section in the XRF image, any 
small holes in the sample were removed by using a lower pixel intensity cut-off to get rid 
of false negative pixel intensity values. Sections with folds were avoided when choosing 
samples for synchrotron imaging. 
All XRF files were then converted into a gray-scale text image using the program smak2txt 
created by Graham George (University of Saskatchewan), allowing them to be opened in 
ImageJ (https://imagej.nih.gov/ij/). Once open in ImageJ, the files were converted into a 
16-bit grey value scale and then saved as a .tiff image to be opened in Adobe Photoshop 
CS6 (https://www.adobe.com/ca/). Adjacent sections were used to carry out 
immunohistochemistry protocols and imaged with a fluorescence microscope. In Adobe 
Photoshop, regions for analysis (mature versus immature cartilage) were selected based on 
the COL10 immunostaining pattern from an adjacent section (mature chondrocyte marker) 
by importing the IHC image as a new layer in the image and adjusting the layer 
transparency and contrast until the two outlines could be overlain to give the best possible 
fit. Sections which were too peripheral were either avoided all together or regions were 
drawn conservatively during analysis to avoid sulfur signal coming from the 
perichondrium.  
Each region of interest for analysis was drawn using the polygon selection tool on the 16-
bit greyscale sulfur map with the COL10 immunostain visible behind it (as a separate layer 
by reducing the sulfur layer opacity) visible, but with the sulfur map selected. The selected 
region was then copied into a new separate layer for analysis. Photoshop by default applies 
fuzziness to a clipped selection when copying it to a new layer or file to keep out of focus 
elements from appearing too crisp in a new layer for creating realistic images, but this 
default was overcome by setting the sharpness setting to 100 % immediately after copying 
to a new layer. The layers were transferred faithfully when using the 100 % sharpness 
setting, except for occasional clipped pixels along the outside edge which appeared very 
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dark and were excluded from the analysis. For each region, the filtered-out pixels (relating 
to tears) were hand selected and an inverse mask was applied, deselecting those pixels. 
This was necessary because Photoshop does not see null values generated by cut off value 
filters in other programs, but instead sees only grey values of 0, which affects the average 
of ROIs if they are included. Average pixel intensity, total pixel intensity, standard 
deviation, total pixels counted from the histogram toolbar were collected for statistical 
analysis.  
XANES spectra (collected as above) were processed using the EXAFSPAK suite of 
programs (http://www-ssrl.slac.stanford.edu/exafspak.html). Using the DATFIT program, 
spectra from tissue sections were fitted with a linear combination of normalized reference 
spectra. Standards were excluded from the refinement algorithm if they contributed to <1 
% of the total spectra.  
 
Images of total protein distribution were calculated from the integrated area under the 
Amide I band (mainly C=O stretch) from 1590 – 1720 cm-1. PG correlated bands 985 – 
1140 cm-1 and the second derivative band at 1374 cm-1 were chosen based on biologically 
validated univariate models (Saarakkala et al., 2010). All data processing and image 
generation was performed using Cytospec software (Cytospec, Version 1.2.04) and Opus 
software (Version 6.5, Bruker, Ettlingen, Germany). 
 
Statistics were carried out in SPSS version 23. Since only the relative difference in sulfur 
between regions was important for this study, the ratio between mature and immature mean 
sulfur values was used to normalize across different experimental runs, giving us an 
internally standardized look at increasing or decreasing relative sulfur levels. The One 
sample t-test was used to measure statistical significance between the mature region and 
the immature region mean intensity (defined as 1.0) with the deviation reported as ± the 
standard error of the mean. For cases where there were two immature regions present 
(corresponding to each end of the bone), the immature region was taken to be the calculated 
average of the two. The 95 % confidence interval with an associated p-value of < 0.05 was 
considered significant.  
 
3.4 Results 
3.4.1 XRF imaging at VESPERS shows a decrease in total sulfur in mature cartilage 
 
To investigate a possible correlation between the maturation state of cartilage and sulfation 
levels, the ratio of total sulfur in mature cartilage versus immature cartilage was quantitated 
at the VESPERS beamline at the CLS. Whole-mount humeri and 10 µm-thick tissue 
sections were stained with Alcian blue stains and Safranin-O stains, respectively, which 
are both cationic dyes that bind to sulfated PGs and show a decrease in mature cartilage 
(Fig. 3.1 A-C)(Deutsch et al., 1995; Farquharson et al., 1994). Safranin-O tissue section 
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staining in the same region supports the case that decreased binding is due to lowered levels 
of sulfated GAGs in mature cartilage, and not a penetration issue as could occur with whole 
mounted humeri. COL10 immunostaining was used as an unbiased marker for identifying 
where to assign regions of interest for mature and immature cartilage (Fig. 3.1 D).   
Sulfur was successfully imaged using XRF, with adjacent sections used for Col10 
immunostaining for all 10 chicken humerus samples (Fig. 3.1 E). Qualitatively, a pattern 
Figure 3.1 XRF imaging of total sulfur validates the loss of proteoglycan staining by Alcian 
blue/Safranin O in mature cartilage. 
Mineralization of perichondral bone is depicted by Alizarin red staining (panel A) along with Alcian blue staining for 
sulfated proteoglycans. Alcian blue staining on its own (panel B) shows a decreased binding ability in the mature 
cartilage region. Safranin O staining of sulfated PGs depicts hypertrophy in mature cartilage (insert C’) along with 
immature chondrocytes (C’’). Immunohistochemistry images of COL10 (panel D) performed on adjacent sections were 
used to define the mature and immature regions for XRF image analysis (white dashed line). Total sulfur maps were 
collected at the VESPERS beamline at the Canadian Light Source (panel E). Quantitation of XRF images for total sulfur 
showed a decrease of 2.7 ± 1.1% in the average total sulfur content of mature cartilage relative to immature cartilage 
(panel F). N = 10. Error bars represent the standard error of the mean. P-values < 0.05 % were considered significant. 
Abbreviations: IC = immature cartilage; MC = mature cartilage; PC = perichondrium. 
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of decreasing sulfur in the central region was easily observed for most humerus samples 
scanned by sulfur XRF imaging. An additional seven 4 % PFA-fixed samples were also 
imaged in the same manner described in Section 3.3.4 VESPERS and the trend in 
decreasing cartilage was also observed (data not shown). A significant decrease (p = 0.04) 
in the average total sulfur content was shown to occur in mature cartilage compared to 
immature cartilage. This decrease in sulfur in mature cartilage was measured on the order 
of 3 ± 1 % (Fig. 3.1 F). This pattern was shown consistently for 9 of 10 samples imaged at 
the VESPERS beamline. Sections collected which exhibited narrowing in the mature 
region (more peripheral and closer to the perichondrium) showed a high sulfur content 
coming from the perichondrium itself (Fig. 3.1 E). Very strongly COL10 immunostained 
regions generally fit well within the low sulfur regions (Fig. 3.1 D-E). The question of the 
biological significance of this small detected decrease in mature cartilage may find an 
answer in knowing the exact chemical form of sulfur lost, whether sulfate esters or proteins, 
and how this loss relates to PG levels.  
 
3.4.2 XANES analysis of sulfur K-edge achieves a good overall fit for cartilage using 
five standards  
A total of 8 standard sulfur compounds (those shown in Fig. 3.2 A) were normalized to 
their respective edge-jump values and were tested in the fitting of combined mature and 
immature chicken cartilage XANES spot-scans. Inorganic (free) sulfate, N-linked sulfate 
esters, and sulfinic acids did not contribute >1 % to the total sulfur signal and were not 
included in the final fit. Five chemical forms of sulfur were determined to be present at > 
1% abundance. The standard curve fitting using these 5 forms of sulfur gave an 
acceptable fit to averaged XANES spot scans from both mature and immature cartilage 
(Fig 3.2 B, C) (residual = 4.7  10-3, 6.2  10-3, respectively). As expected, most sulfur 
present in these spot scans was in the form of sulfate esters (77 ± 2 % for immature and 
70 ± 11 % for mature). The secondary form of sulfur in mature and immature cartilage 
tissue was found to be sulfonic acids at 22 ± 11 % and 14 ± 2 %, respectively. Thioethers, 
sulfoxides and disulfides were measured to be 7± 1 %/6 ± 2 %, 1 ± 0.1 %/ 2 ± 1 %, and 
0.9 ± 0.2%/ 1.0 ± 0.4 % for immature/mature cartilage, respectively.  
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Figure 3.2 Analysis of XANES spectra fittings 
with standard sulfur compounds has revealed the 
five major forms of sulfur present in chick 
cartilage. 
The normalized standard absorption curves for a 
range of different forms of sulfur found in biology are 
shown in Panel A. The standard curve fittings for 
combined averaged XANES spot scans contributing 
>1 % abundance to mature cartilage are depicted in 
Panel B. The contributions of the five major forms of 
sulfur present in mature and immature cartilage are 
listed in the table in panel C. The relative abundances 
of the five forms of sulfur given in panel C are very 
similar between mature and immature cartilage. N = 
4 using an averaged spectrum taken from 3-4 spots 
per region per sample. Error bars represent the 
standard error of the mean with respect to the 
variability of component composition between 
individual samples 
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3.4.3 Chemically specific XRF imaging reveals that PG sulfate esters decrease in 
mature cartilage  
Chemically specific XRF maps of sulfonic acids and sulfate esters were generated for 6 
humerus samples and indicated a significant decrease in sulfate ester levels in mature 
cartilage relative to immature cartilage. A map collected at 2474.4 eV composed of lower 
oxidation states of sulfur was subtracted from maps taken subsequently at 2477.6 and 
2479.2 eV (Fig 3.3 A-D). A map of total sulfur taken at 2500 eV was also collected as a 
comparison between sulfate esters and total sulfur (Fig. 3.3 E). COL10 immunostaining on 
adjacent sections was used to determine the mature and immature cartilage regions as 
outlined by a white dotted line (Fig. 3.3 F). Sulfate esters maps were successfully 
generated, along with maps of sulfonic acids (Figs. 3.3 G, H). Quantitation of these images 
revealed that sulfate esters in mature cartilage were found to decrease significantly 
compared to immature cartilage, on the order of 14 ± 3% (p = 0.008), whereas total sulfur 
was found to decrease by 11 ± 4 %, though non-significantly (p = 0.06) (Fig. 3.3 I). Sulfonic 
acids, on the other hand, increased slightly (4 ± 3 %), but non-significantly (p = 0.4) in the 
mature cartilage region, and showing a large variation in patterns between samples. The 
much bigger difference between total sulfur and sulfate ester levels quantified at SXRMB 
might be partially explained by sulfonic acids increasing, whereas sulfate ester levels were 
found to decrease.  
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Figure 3.3 Chemically specific XRF imaging shows 
that sulfate esters specifically decrease in mature 
cartilage. 
Maps at the energies of 2474.4, 2477.6, and 2479.2 eV 
were collected representing background sulfur signal and 
the on-peak values of sulfonic acids and sulfate O – esters, 
respectively (A-D). A map at 2500 eV was collected to 
show total sulfur (E). COLX immunoassays were again 
used to define regions of interest for mature versus 
immature cartilage (F). Chemically specific maps for O-
linked sulfate esters and sulfonic acids were reconstructed 
using a weighted combination of 2477.6 eV and 2479.2 eV 
maps, after each having had the 2474.4 eV map 
background subtracted (G, H). (I) Quantitation of the 
chemically specific imaging data from N =6 individual 
chicken humeri shows that sulfate esters decreased 13 ± 3 
% in mature cartilage compared to immature cartilage 
versus 11 ± 3 % for total sulfur. Quantitation of sulfonic 
acids revealed no significant difference between mature 
and immature cartilage. N = 6. All bars represent the mean 
± standard error of the mean. Abbreviations: IC = 
immature cartilage; MC = mature cartilage. 
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3.4.4 FTIR imaging shows no significant decrease in proteins or PGs in 
mature cartilage 
The integrated amide I peak (1590 – 1720 cm-1) in the infrared spectrum map was used to 
depict total protein levels (3.4 A).  The representative chondroitin sulfate (PG) bands 985 
– 1140 cm-1, and the second derivative peak at 1374 cm-1 are shown normalized to the 
amide I band to minimize tissue thickness differences (3.4 B and D). No significant 
differences were shown between mature and immature regions for proteins or either of the 
PG bands. To explore whether normalization by area scaling to the amide I band to control 
for thickness differences was masking differences between regions, the 985-1140 cm-1 
integrated region was also measured without normalization to the amide I peak, and this 
analysis also showed no significant trend in mature PG content (Fig. 3.4 C). PGs measured 
with the 1374 cm-1 second derivative band were shown to decrease non-significantly. 
Regions of interest were assigned based on COL10 immunostaining of an adjacent section 
(Fig. 3.4 E). A side by side comparison showing the relative amounts of each of the 4 bands 
analyzed for mature versus immature cartilage is shown in Figure 3.4 F. FTIR image 
analysis reveals that in mature cartilage compared to immature cartilage, protein amide I 
content did not change significantly (decreasing 5 ± 3 % p = 0.17), while normalized PG 
content according to the bands 985 – 1140 cm-1 and 1374 cm-1 also did not decrease 
significantly (4 ± 4 %; p = 0.25 and 3 ± 3 %, p = 0.33), respectively. The non-normalized 
PG marker band of 985 – 1140 cm-1 also did not decrease significantly (7 ± 5 %; p = 0.19) 
in mature cartilage. 
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3.5 Discussion 
The focus of this study was to present data exploring the relationship between the 
maturation state of cartilage and sulfate levels in the ECM and our findings did show a 
significant reduction in total sulfur (2.7 ± 1.1 %, p = 0.04) at the VESPERS beamline, and 
in sulfate esters (13 ± 3 %, p = 0.008) in mature cartilage relative to immature cartilage.  
The decrease in total sulfur found (11 ± 4 % taken at SXRMB) is in agreement with a 
previous study using a different technique, electron probe, which showed an approximate 
16 % decrease in (overall) sulfur content for spot scans in mature chick cartilage, (Hargest 
et al., 1985). This value could be somewhat biased compared to our data because of the 
much lower area examined by spot scan analysis compared to XRF image analysis. A 
decrease in bulk sulfur content between immature cartilage and fully mineralized cartilage 
was reported in pig, changing from 3.5 % to 0.2 % total dry weight (Althoff et al., 1982), 
although this is not a comparable decrease since we were not looking at late-stage fully 
mineralize cartilage. Compared to other imaging studies, our calculated value for the drop 
in total sulfur levels in mature cartilage is identical within the errors to the decrease in 
sulfur levels reported in zebrafish (11 ± 4 %, versus 11 ± 2 %), respectively (Hackett et al., 
2016). Chemically specific XRF imaging based on regions given by COL10 expression 
have revealed a significant decrease of 13 ± 3 % in sulfate ester levels in mature cartilage. 
Figure 3.4 Infrared imaging of protein content and two PGs 
bands revealed no significant decrease in proteins or PG 
content in mature cartilage. 
The integrated amide I band (Panel A) was used to measure total 
protein content. PG content measured using the 985-1140 cm-1 
band, with and without normalization to amide I, are shown in 
panels B and C, respectively. The second derivative map taken at 
1374 cm-1 was a second PG band highly correlated with sulfated 
chondroitin sulfate used to measure PG content (Panel D). COL10 
immunohistochemistry performed on adjacent tissue sections was 
used to determine mature and immature cartilage regions. Panel F 
is a bar graph showing the relative integrated band areas for 
mature versus immature cartilage analyzed using a one sample t-
test analysis. No bands showed significant differences between 
regions, although all PG bands and the amide I band showed slight 
decreases in mature cartilage. N = 7. Error bars represent the 
standard error of the mean. Abbreviations: IC = immature 
cartilage; MC = mature cartilage. 
 
49 
Sulfate ester content in zebrafish was not reported so no comparison can be made (Hackett 
et al., 2016).  
The methodology of using XRF imaging for spatially separating zones of maturation within 
a tissue is useful for tracking changes in the ECM occurring through process of 
hypertrophy, since mature chondrocytes arise adjacently from immature chondrocytes. The 
chemically specific imaging approach holds very important information about the matrix 
due to this spatial relationship between developing chondrocytes, and can even be used to 
zoom in at the level of the cell to see more local sulfur concentrations. There was a 
discrepancy in the total sulfur values for the six samples measured at both the VESPERS 
and SXRMB beamlines 4 ± 2 % versus 10 % ± 4 %, respectively. Due to the high energy 
pink beam X-rays used (15 keV), multiple elements are excited above the sulfur K-edge. 
Using a correlation plot to look at other elemental maps which may correlate with sulfur 
during total sulfur imaging at VESPERS, there seemed to be a linear trend between chlorine 
and sulfur levels. Chlorine is the main element of concern for overlap between K-edge 
peaks since chlorine is the Z+1 mass neighbour of sulfur. This is the most probable 
explanation of why the differences in total sulfur between immature and mature regions at 
VESPERS was much lower than the same measurement at SXRMB using a much lower 
excitation energy. The chlorine maps visually appeared to show a similar distribution to 
sulfur maps, but with more chlorine in the mature region than with the sulfur maps. This is 
a problem that does not occur at the SXRMB beamline, where monochromatic energies are 
used for each map. 
Another expected source of error comes from the fact that the regions of interest were 
determined by the best fit of an adjacent section used for COL10 IHC, and that human 
judgement inevitably impacted to some extent where the boundaries of COL10 expression 
in regions were drawn. The fact that sections are adjacent to each other and not the same 
or identical makes it a source of error is introduced which can never be accounted for. 
Sulfur XANES is a technique applicable to the determination of sulfur species contained 
in complex mixtures (Gambardella et al., 2015; George et al., 1991; Gnida et al., 2007; 
Greenfield et al., 2015; Hackett et al., 2012; Pickering et al., 1998). The same 5 sulfur 
species were present at greater or equal to 1 % abundance for both mature and immature 
cartilage. In decreasing order, these sulfoforms were: sulfate-O-esters, sulfonic acids, 
thioethers, disulfides, and sulfoxides. XANES spot scans estimated that 77 ± 2. % of sulfur 
for immature and 70 ± 11 % of sulfur for mature cartilage could be attributed to sulfate 
esters. Sulfate O-esters, sulfonic acids, and thioethers were all compounds identified in 
zebrafish cartilage by XANES measurements, though disulfides and sulfoxides were 
excluded from their final fit (Hackett et al., 2016). Sulfate ester degradation in the lysosome 
releases free sulfate as an end product of PG breakdown, and these free sulfate groups are 
generally not recycled back into PGs in tissue culture experiments (Harper et al., 1993; 
Rome and Hill, 1986). Including a free sulfate standard in our analysis, we found no free 
sulfate contributing to the overlapping peaks at 2478 eV. This is only to say that any sulfate 
esters lost in mature cartilage are not remaining as free sulfate for long in the ECM. The 
XANES data are based on spot sized data from individual samples, and since errors must 
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be added together when making a direct comparison, then statistical differences between 
regions for individual component comparisons (e.g. the sulfate ester difference measured 
by XANES spot scans for our data set would measure 8 ± 13%) could not be inferred 
accurately without using a larger number of spot scans.  
The high levels of sulfonic acids (14 ± 2 % in immature, and 22 + 11 % in mature cartilage) 
are an interesting finding of this analysis, since the only other study using chemically 
specific XRF on developing cartilage noted negligible levels of sulfonic acids in zebrafish 
(Hackett et al., 2016). No significant relationship between sulfonic acid levels and 
maturation state was found for our samples. It is tempting to speculate that the identity of 
this sulfonic acid molecule could be the main sulfur donor to the sulfotransferase enzymes, 
phosphoadenosine phosphosulfate (PAPS)(Klaassen and Boles, 1997), especially because 
of the lack of a free sulfate detected by XANES fitting analysis.  
FTIR analysis showed no significant changes to either PG band analyzed for mature 
cartilage versus immature cartilage, indicating that at least some of the sulfate esters in the 
mature matrix are disappearing independently of overall PG levels. The two spectral 
regions of 985-1140 cm-1 and 1374 cm-1 were used to represent overall PGs in the matrix 
(Boskey and Pleshko Camacho, 2007; Kim et al., 2005; Saarakkala et al., 2010). This 
method to measure CS proteoglycans is reliant on the strength of a univariate analysis 
which identified these two PG regions as the most significant changes seen varying with 
CS concentration. The 985-1140 cm-1 and 1374 cm-1 PG bands in their study were further 
assessed using varying amounts of Col2 and Aggrecan, by biochemical determination of 
GAG content based on estimates from this method, and they were also validated in articular 
cartilage - all of which add weight that most of the variance in these bands is due to CS, 
and not another component in cartilage (Boskey and Pleshko Camacho, 2007). If the PG 
content analysis is not faithfully estimating PG content and is overestimating losses 
observed in mature cartilage, then the same conclusions would be drawn from this study 
regardless; i.e. sulfate esters are decreasing despite no change to PG content between 
regions implying a loss of sulfate groups from PGs. If, however, FTIR analysis of PGs is 
significantly underestimating PG losses in mature cartilage, then it would weaken support 
for the notion that PG loss is the main reason for lowered sulfate esters in mature cartilage.  
The loss of sulfate esters despite no significant loss of PGs in mature cartilage suggests 
two different but not exclusive possibilities as to how the sulfate levels might be changing. 
One possibility is that there is a less-sulfated CSPG product secreted in mature cartilage. 
Lowered levels of PG sulfation during mature cartilage PG synthesis compared to 
immature cartilage PG synthesis is not implausible - it is already known that Carbohydrate 
sulfotransferase 11/Chondroitin-4-sulfotransferase-1 (CHST11/C4ST-1)) gene expression 
ceases in mature cartilage, even though it is highly expressed in immature cartilage 
(Kluppel et al., 2002). A second possibility for disappearance of PG sulfur signals from 
mature cartilage is that sulfatases are acting in the ECM to release sulfate ester groups 
which are then removed or converted to another form of sulfur and removed through some 
clearance mechanism. The regulated removal of CS molecules in-situ in the ECM by 
sulfatases has not been reported in the literature; but in humans 15 sulfatases are known to 
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exist with 2 heparan sulfate specific sulfatases SULF1 and SULF2 acting exclusively in 
the ECM, and an additional 3 showing unknown substrate activity (Hanson et al., 2004).  
Taken with the finding of significantly decreased sulfate esters in the matrix, and 
considering that no significant losses of PGs from the matrix were found, the obvious 
candidate for the cause of this loss of sulfate esters from that matrix is a sulfatase. 
Specifically, this sulfatase gene would be expected to be expressed highly in mature 
cartilage relative to immature cartilage, corresponding to the decrease seen for sulfate 
esters in mature chondrocytes. Our preliminary RNA in-situ hybridization analysis for 
ARSB and GALNS in chicken showed no substantial over-background signal (supplemental 
Fig. A1). Only three CS sulfatases are known, and both are found in lysosomes, although 
there is at least one published record of ARSB being found in the ECM in liver (Mitsunaga-
Nakatsubo et al., 2009). There are other sulfatases, such as ARSJ, which have unknown 
substrate specificity and site of action and perhaps most interestingly, the sulfatase ARSI 
which has no clear substrate preference, has been shown to be secreted from human 
epithelial cells (Mikami and Kitagawa, 2013; Oshikawa et al., 2009). These may be good 
candidates for follow up studies to try to identify possible extracellular CS sulfatases.  
Future studies will aim to address the exact mechanism responsible for sulfur loss in mature 
cartilage. It is important to keep in mind that cartilage is a mechanically responsive 
element, such that small local decreases in PGs can, in principle, have a large effect on 
mechanical forces and also growth factor distribution. Any direct evidence for the cause of 
differences in CS sulfation, which might lead cells towards certain developmental 
pathways could establish new avenues of treatment for cartilage diseases or better 
manipulation of artificial cartilage constructs (such as controlling range and/or the rate of 
growth factor diffusion). The loss of sulfated proteoglycans in mature cartilage is now 
shown to be a feature of endochondral bone formation that is shared for at least some bony 
fishes and avians, but data from more species are needed before making claims about 
conservation of this feature. Because of the sensitivity of XANES to sulfur neighboring 
groups, it would also be very interesting to see if it were possible to differentiate between 
and image different CS units directly, which differ only in their position(s) of sulfation.  
 
3.6 Conclusions 
Sulfate esters and PGs were visualized directly and quantitated to find out if the cartilage 
maturation state follows the same pattern as the sulfation status of PGs in the ECM. The 
hypothesis that we put forward was that sulfate esters levels decrease in mature cartilage. 
Indeed, sulfate ester levels were shown to decrease significantly by 13 ± 3 in mature 
cartilage. Sulfate ester level quantitation along with biochemical data gathered by FTIR 
indicates that sulfate ester levels in mature cartilage decrease, despite no significant 
decrease in PG levels. Two possibilities for these losses in sulfate esters include turnover 
of PGs with significantly less sulfation during replacement in MC, or that an 
uncharacterized enzyme or mechanism is removing sulfate esters from the ECM directly.  
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A clear connection has been demonstrated between sulfate esters levels and the maturation 
state of the underlying chondrocytes. This feature of endochondral bone development 
seems to have been passed down through vertebrates, appearing in at least both zebrafish 
and chicken. Sulfur is known to be critical to the function of PGs in the matrix, both 
biomechanically and related to the timing of development. A high amount of sulfation is 
required for PGs to function optimally within the skeleton. There may be a fine balance in 
cartilage between the high levels of sulfate esters required for optimal biomechanical 
functioning of PGs on one hand, and the lowering of sulfation levels to possibly sub-
optimal levels at the correct time and by the correct amount to allow maturation to proceed 
on the other.  
 
3.7 Supplemental 
This supplemental is provided to include the results from the RNA in-situ hybridization 
experiments performed as part of my master’s degree project. Gene expression data for 
Galns and Arsb have been published in the mouse (Ratzka et al., 2010), but not in the 
chicken, so the results obtained using a positive control along with data obtained from the 
mouse are the best indications of whether the probes and technique were successful, even 
if there was no strong expression shown for either probe in cartilage. 
3.7.1 RNA in-situ hybridization results for GALNS and ARSB expression in stage 
HH36 cryo-sectioned chick humerus 
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Figure S1 RNA in-situ analysis of the chicken 
GALNS and ARSB genes. 
Panel A shows a positive control COL2A1 RNA in-situ, 
with specific expression seen in HH36 mature cartilage. 
ARSB expression did not show a strong expression 
pattern (Panel B). GALNS expression was ubiquitous 
throughout the element (Panel C). Some ARSB 
expression was seen in the growth plates for the ulna and 
radius (center and bottom left of panel D). 
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CHAPTER 4 
 
4.1 Discussion and Conclusions 
 
Sulfated PGs in the cartilage ECM are necessary for normal biomechanical functioning of 
this tissue; but losses in PGs or sulfur regulating enzymes are known to cause severe growth 
defects related to altered maturation timing in chondrocytes. The hypothesis set out in 
Chapter 3 for the research based component of my thesis was that sulfate esters disappear 
from mature cartilage during endochondral bone development. The results of this research 
have provided valuable information regarding the spatial regulation of sulfur in 
development.  
Total sulfur elemental mapping as well as chemically specific mapping was successfully 
carried out and differences were tested for statistical significance between mature and 
immature cartilage developmental regions. Previous findings have reported decreasing 
sulfur levels in mature cartilage based on a single chick electron probe study and one study 
in zebrafish. We reported a 10 ± 4 % decrease in total sulfur in mature cartilage in chicken 
at SXRMB. In zebrafish, XRF imaging analysis revealed a decrease of 11 ± 2 % (Hackett 
et al., 2016), which matches very closely with our data, even across species. A 16 % 
decrease was reported for sulfur levels in mature chicken cartilage measured by electron 
probe (spot scans), which is a slightly higher decrease than our estimate (Hargest et al., 
1985). Our approach was technically limited because of the use of adjacent sections to 
define regions of interest, leading to a source of error in defining our mature and immature 
regions for analysis. In the future, sections used for synchrotron imaging would be best 
conserved and used for immunostaining to define regions more precisely. A similar 
limitation in drawing the regions by hand came from the human error associated with 
drawing regions, even though the approach was to base this drawing on marker protein 
expression. Even with the variability between immunostaining different tissues on different 
days, it would be good to run the analysis again with a computer assisted brightness cut-
off value to see if very strong COL10 expression (capturing only morphologically mature 
chondrocytes) correlated any better with sulfur levels than we found in this study as we 
suspect it may. 
FTIR imaging was used to get a measure of PG content differences between mature and 
immature cartilage regions in developing chick cartilage. The two bands used (985 – 1140 
cm-1 and the 1374 cm-1 2nd derivative peak) were shown to be highly correlated with CS 
content in cartilage cell culture, articular cartilage sections, and in standard mixtures of 
PGs and collagen (Boskey and Pleshko Camacho, 2007; Kim et al., 2005; Saarakkala and 
Julkunen, 2010). Our analysis indicated that no significant decrease in PG content was 
occurring in mature cartilage compared to immature cartilage. These results suggest that 
the loss of sulfate esters in mature cartilage is not due to a loss in overall PGs from these 
regions. The two main possibilities that we suggest are that either sulfate esters are being 
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lost directly in the matrix due to the action of an unidentified sulfatase, or else that PGs are 
being recycled in this region with less sulfation upon their synthesis and re-secretion. 
The many processes involved in PG synthesis and their turnover by the cell were outlined 
in Chapter 2. Human Aggrecan molecules in the growth plate have been estimated to have 
a three and a half year half-life, with smaller fragments estimated to persist for up to 20 
years (Maroudas et al., 1998). At the same time, the pattern of sulfation happens throughout 
the lifetime of an individual, shifting towards more 6-O sulfation of GalNAc residues of 
CS. The sulfatase enzymes are required within cells to remove the sulfate groups for 
endoglycosidases in the lysosome to be able to degrade PGs into constituent 
monosaccharides (Diez-Roux and Ballabio, 2005; Hanson et al., 2004). Heparin/Heparan 
sulfate is known to interact with hormones and growth factors in the ECM, playing 
important roles in development, but this idea is not readily extended to the CS 
proteoglycans (Otsuki et al., 2010). The lysosomal CS sulfatase Arsb has been reported to 
be found pericellularly in mouse liver cells (Elvevold et al., 2008; Mitsunaga-Nakatsubo 
et al., 2009), and there remains a number of uncharacterized putative sulfatases which may 
be active in the ECM towards chondroitin sulfate (Ratzka et al., 2010).  
The hypothesis put forth was ultimately supported based on quantitative sulfate ester XRF 
imaging analysis and FTIR imaging analysis for PG content in developing chick cartilage. 
Future studies should focus on identification of a sulfatase which could be acting to reduce 
sulfate esters in the ECM independently of PG degradation. This could be achieved with 
differential gene expression analysis to look for upregulated sulfatase genes found in 
mature cartilage compared to immature cartilage. Chemically specific XRF imaging is a 
powerful tool which can reveal much in the way of health-related information about a given 
sample. Osteoarthritis is one such example of a research field which could benefit from the 
use of chemically specific imaging to look at early signs of OA lesions. Critical losses of 
sulfate ester groups from the ECM in OA lesions, could be related to changes in the 
underlying state of chondrocytes in osteoarthritic tissue. It may be interesting to see what 
is happening to the sulfur pool in cartilage when sulfur is clearly not being replaced quickly 
enough to repair tissue – perhaps it is locked up in a different chemical state due to 
metabolic stresses places on this tissue, and perhaps this could lead to a shift in our 
understanding of how to re-energize the normal PG synthesis pathway. 
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APPENDIX 
 
Appendix – OA Human Knee Imaging Study Overview 
Introduction 
 
Osteoarthritis is a not a degenerative disease of cartilage, but rather, it is a mechanical 
failure of function in areas of overloading causing irreplaceable damage to an articular 
cartilage surface which is actively trying to repair itself (Dieppe, 2011). The abnormalities 
in osteoarthritic cartilage which have been reported as pathologies, such as elevated 
cytokines, toxic radicals, and matrix degrading enzymes might be more accurately viewed 
as results of cartilage attempting to repair itself rather than a run-away process (Brandt et 
al., 2008, 2009). Articular chondrocytes implicated in the disease process exhibit many 
similarities to chondrocytes undergoing normal development which are closely related to 
the degradation of the extracellular matrix (ECM) and joint integrity (Pitsillides and Beier, 
2011).  
Sulfated proteoglycans (PGs) play a major role in resistance to compressive forces 
(Aumailley and Gayraud, 1998; Chahine et al., 2005), but as with losses of PG as seen in 
OA, there is a growing body of evidence that implicates developmental processes in the 
etiology of the disease (Pitsillides and Beier, 2011). In mutant animal models of cartilage 
diseases, lowered levels of PGs lead to stunting of bone growth, as well as precocious 
maturation of chondrocytes and early bone formation (Cortes et al., 2009; Domowicz et 
al., 2009; Eames et al., 2011; Hackett et al., 2016). Sulfate ester levels in normal zebrafish 
were shown to be correlated with the maturation state of the underlying cartilage (Hackett 
et al., 2016). The sulfation pattern of the most abundant cartilage PG, chondroitin sulfate 
(CS), refers to the ratio of 4-sulfated versus 6-sulfated CS disaccharides, and this has been 
shown to decreases through the normal course of ageing (even though healthy cartilage 
thickness does not change significantly with age)(Bayliss et al., 1999).  
Chemically specific sulfur imaging is a valuable technique which can reveal the spatial 
distribution of both high and low oxidation state specific chemical forms of sulfur present 
in biological samples (Pickering et al., 1998; Pickering et al., 2009). Having previously 
characterized sulfate ester levels in chick cartilage during maturation (Chapter 3), we 
showed that decreases in sulfate ester levels were significantly correlated with cartilage 
maturation and also showed the differences in sulfur chemical speciation between regions 
by the use of X-ray absorption near edge structure (XANES) spectroscopy spot scan 
analysis. The hypothesis that we wanted to test with this OA human knee sample data set 
was that sulfate ester levels decrease first in the middle and deep zones (where most of the 
compressive strength is found) of damaged cartilage. This study would also be an 
exploration of the different chemical forms of sulfur present distributed in OA and non-
OA tissue to look for key differences in how this sulfur is metabolised differently in the 
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two cases. The data set collected was a qualitative set of images from one OA knee sample 
imaged at both the VESPERS and SXRMB beamlines at the Canadian Light Source (CLS) 
to look for any observable trends (Fig. A1).  
 
5.1.2 Results and Discussion 
 
Qualitatively, chemically specific XRF imaging of sulfate esters shows major differences 
in sulfate ester, sulfonic acids, and phosphorus levels between OA lesion tissue and 
adjacent healthy cartilage, along with zone specific changes. Chemically specific XRF 
imaging was carried out at the SXRMB beamline at the CLS for one sample of OA tissue 
obtained from a knee replacement donor program. Four other samples comprising two OA 
samples obtained through the total knee replacement donor program, and two age-matched 
control samples obtained through the body bequeathal program were also imaged for total 
sulfur at the VESPERS beamline at the CLS (data not shown). Close-up images of the 
medial tibial plateau taken before cryosectioning (Fig. S1, panels A and B) shows a 
translucent appearance to cartilage and a milky white appearance (presumably the calcified 
layer of cartilage and underlying bone). The overall thickness of the normal appearing 
cartilage adjacent to the defect (panel C) is much greater than that within the defect (panel 
D). Chemically specific imaging was carried out at two locations, one at a normal adjacent 
cartilage site, and the other one at the defect (boxes, panel E). Chemical maps were 
processed for total sulfur, sulfate esters, sulfonic acids, and phosphorus in normal cartilage 
and the defect (Panel F). As can be seen in panel C, the presumptive cartilage region has 
higher levels of sulfur. Cell clusters in normal appearing cartilage are distributed evenly 
throughout the presumptive middle and deep zones. In the high resolution 4x4 images in 
panel C, the interterritorial cartilage, which is a region closely surrounding articular 
chondrocytes clusters, is seen as circles of very high sulfur content. It is thought that this 
territorial zone thickness is protectant of articular chondrocytes and contributes to their 
resilience (Muir, 1995). In comparison, OA regions 5 and 6 (panel D), which appear closest 
to the center of the defect, show very decreased levels of total sulfur. The highest levels of 
sulfur are in the presumptive underlying bone region, most obvious in zone 6 cartilage, 
where the remaining cartilage is the thinnest (panel D). Coincidentally, cells lose their even 
distribution pattern as well in zone 5 compared to zones 4 and 6. Territorial region as seen 
in the 4x4 images in panel D show no distinct demarcation of territorial bundles in zones 
4 and 5; but interestingly, it shows up again in zone 6, which may be an indicator of 
regeneration. Chemically specific imaging of cartilage (panel F) reveals that total sulfur 
distribution shows differences with sulfate ester distribution in the cartilage of OA defect 
tissue, even though these two maps look very similar in normal thickness cartilage. 
Specifically, total sulfur levels dropped dramatically in the OA sample across all regions. 
Surprisingly, sulfate ester levels did not follow the same trend as total sulfur, and appeared 
to decrease most dramatically in lower regions, likely subchondral bone. Sulfonic acids 
may be one of the causes for this difference between sulfate esters and total sulfur, as they 
showed a major loss in superficial and deep regions. Phosphorus, which is associated with 
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matrix mineralization, was increased moderately in the superficial and deep regions. 
Interpreting whether this phosphorus change is real or artefactual is difficult because 
tissues were formalin fixed and demineralized, and phosphorus is a soluble ion. 
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Figure A1 OA human knee imaging study overview.  
Total sulfur and chemical specific XRF imaging analysis shows dramatic losses of total 
sulfur and sulfate O-esters in the OA defect, as well as differences in sulfonic acids and 
phosphorus distribution. The demineralized OA medial tibial plateau (A, B) was cut down 
in size and sectioned to 10 µm thickness for XRF imaging. Regions 1, 2, and 3 exhibited 
no evident wear and were relatively normal thickness for use as an internal normal control. 
Regions 4, 5, and 6 are directly from or adjacent to the defective area exhibiting very thin 
cartilage (B). Normal thickness cartilage was imaged at 15  15 µm and 4x4 pixel size to 
show sulfur distribution at different scales (C). Defective cartilage exhibited much less 
sulfur in across the thickness of the tissue (D). In region 6, closest to the defect, sulfur in 
the matrix was highly restricted to areas pericellular to chondrocyte clusters. Regions used 
for chemical specific imaging focused in below the articular cartilage to show a wider 
portion of the sample (E). Chemical specific imaging maps of total sulfur, sulfate O-esters, 
sulfonic acids, and phosphorus are shown for normal width and focal defect regions (F). 
Total sulfur decreased everywhere in the defective cartilage compared to normal control 
cartilage, but due to the disturbed zonal structure of the OA defect, conclusions on exact 
regional differences can not be drawn. Sulfate O-esters decreased throughout the chondral 
defect, but showed interesting differences from total sulfur; whereas phosphorus, a marker 
of calcification, increased in the cartilage defect. Abbreviations: AS = towards articular 
surface; OA = osteoarthritis; SCB = towards subchondral bone. 
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